




Congenital Diaphragmatic Hernia (CDH) is defined by the presence of an orifice in the diaphragm, more often left
and posterolateral that permits the herniation of abdominal contents into the thorax. The lungs are hypoplastic
and have abnormal vessels that cause respiratory insufficiency and persistent pulmonary hypertension with high
mortality. About one third of cases have cardiovascular malformations and lesser proportions have skeletal, neural,
genitourinary, gastrointestinal or other defects. CDH can be a component of Pallister-Killian, Fryns, Ghersoni-Baruch,
WAGR, Denys-Drash, Brachman-De Lange, Donnai-Barrow or Wolf-Hirschhorn syndromes. Some chromosomal
anomalies involve CDH as well. The incidence is < 5 in 10,000 live-births. The etiology is unknown although clinical,
genetic and experimental evidence points to disturbances in the retinoid-signaling pathway during organogenesis.
Antenatal diagnosis is often made and this allows prenatal management (open correction of the hernia in the past
and reversible fetoscopic tracheal obstruction nowadays) that may be indicated in cases with severe lung
hypoplasia and grim prognosis. Treatment after birth requires all the refinements of critical care including
extracorporeal membrane oxygenation prior to surgical correction. The best hospital series report 80% survival but
it remains around 50% in population-based studies. Chronic respiratory tract disease, neurodevelopmental
problems, neurosensorial hearing loss and gastroesophageal reflux are common problems in survivors. Much more
research on several aspects of this severe condition is warranted.
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Disease name/synonyms
Congenital Diaphragmatic Hernia (CDH), ORPHA2140,
OMIM 142340, 610187, 306950 and 222400
Definition
CDH consists of a posterolateral defect of the dia-
phragm, generally located on the left side, that allows
passage of the abdominal viscera into the thorax. The
mediastinum is displaced to the contralateral side, the
lungs are hypoplastic (Figure 1) and their arterioles are
abnormal causing pulmonary hypertension. Respiratory
and cardiovascular functions are severely compromised
at birth and this, together with the frequently associated
malformations, cause considerable mortality and mor-
bidity. CDH was described many years ago [1,2] but sur-
vival after repair was not achieved until the 20th century.
Pioneers of pediatric surgery [3] reported amazingly low
mortalities until the actual severity of the condition
surfaced when abortions, stillbirths and pre-hospital
deaths were considered, adding a “hidden mortality” to
operative and postoperative demises [4]. The pathophy-
siology of lung insufficiency and persistent pulmonary
hypertension that threaten survival are currently better
understood, but the results remain disappointing since
mortalities near 50% are still reported when all deaths
are taken into account in population-based series [5].
CDH management indeed remains one of the major
challenges of perinatal medicine and surgery and active
research on its mechanisms is warranted.
Epidemiology
CDH is a rare condition that occurs in < 1-5:10000
births [6]. It seems to be slightly more frequent in males
and less frequent in blacks [7,8].
Clinical features
CDH can be detected during fetal life when screening
ultrasonography demonstrates herniation of the intestine
and/or the liver into the thorax. Polyhydramnios may
lead to antenatal diagnosis in some severe cases [9].
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Neonatal symptoms of CDH are heralded by respira-
tory distress with insufficient oxygenation, excavated
abdomen with sternal protrusion and displacement of
the heart sounds to the contralateral side. In severe
cases, APGAR scores at 1 and 5 minutes are low
[10,11]. Respiratory bruits are absent or decreased on
the affected side. Unless energetic treatment is under-
taken, respiratory condition deteriorates rapidly until
the patient dies. The symptoms of insufficient gas
exchange are associated with those of persistent pul-
monary hypertension [12,13] caused by arteriolar con-
striction and closure of the pulmonary arterial bed
that forces maintenance of a pattern of persistent fetal
circulation in which the blood from the right ventricle
is shunted to the left heart preventing effective gas
exchange. In some cases, this pulmonary hypertension
intervenes after some hours during which adaptation
to a post-natal circulatory pattern with patent pul-
monary circulation had taken place. Hypoxia, acidosis,
stress or other causes may bring this “honeymoon”
period to an end and re-establish the fetal pattern
[14].
In some cases without neonatal symptoms, CDH may
manifest itself at any age by mild respiratory distress or
it can even be an unexpected finding during a medical
check-up for other reasons [15]. In these cases, a hernial
sac is more often present [16].
Other organs may be involved in CDH [17] because
associated malformations are frequent [18]. The heart
and great vessels are often abnormal in CDH patients.
Cardiovascular defects like peri-membranous ventricular
septal defect, cardiac outflow anomalies (tetralogy of
Fallot, double outlet right ventricle, transposition of the
great vessels and others) and abnormal great vessels
(right aortic arch, double aortic arch, truncus arteriosus,
abnormal subclavian arteries and others) are found in
about one third of CDH patients [19,20]. Heart hypopla-
sia, particularly of the left side [21], has also been
described [22] but its participation in the clinical picture
is still unclear.
Musculoskeletal defects like anomalies of the limbs or
of the number and shape of the vertebral bodies and/or
ribs [18,23-25], neural tube defects [18,26], abdominal
wall defects [27], craniofacial defects [28] or urinary
tract anomalies [29] are also found. The parafollicular
C-cells [30] and enteric innervation are deficient and
might account for some dysfunctions [31]. Finally, the
presence of the intestine in the thorax during late fetal
development causes malrotation and/or malfixation [32]
that can further complicate the disease [33].
Etiology
The causes of CDH are largely unknown. Most cases are
isolated, but associated malformations are often
Figure 1 A: Plain X-ray of the thorax of a newborn with CDH. There are bowel loops into the left hemi-thorax, the mediastinum is displaced
to the contralateral side and the space occupied by the lung is reduced. B and C: At laparotomy, a left, posterolateral diaphragmatic hernia was
discovered. In B, small bowel loops can be seen entering the thorax through the orifice. In C, this is seen after reducing the contents of the
hernia. D: The patient died of severe persistent pulmonary hypertension days later. At autopsy, extreme left lung hypoplasia and less severe right
lung hypoplasia were discovered.
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observed [34], sometimes as components of Pallister-
Killian and Fryns [35], Ghersoni-Baruch [36], WAGR
and Denys-Drash [29,37], Brachman-De Lange [38],
Donnai-Barrow [39] or Wolf-Hirschhorn [40] syn-
dromes. CDH is also observed in some chromosomal
anomalies whether related or not to these syndromes
like 9p tetrasomy [41], 11q23-qter duplication [42],
15q24-26 [43], 15q26 [44], 1q41-q42.12 [39,45] and
8p23.1 [46] deletions. Null-mice for several genes, like
shh transcription factors Gli 2 and Gli3 [47], Slit3
[48,49], COUP-TFII [50], Fog2 [51], Wt1 [52] and
FGFLR-1 [53] have CDH.
The orifice in the diaphragm is caused by delayed or
disturbed separation of the thoracic and abdominal
compartments of the body by closure of embryonic
pleuroperitoneal canals effected by growth of the post-
hepatic mesenchymal plate and of the pleuroperitoneal
folds [54-57].
CDH occurs more often on the left side (4:1) [58]. In
some rare instances [59], the defect is a true agenesis of
the hemidiaphragm [60], but in most cases it is limited
to the posterolateral area. Less often, there is a hernial
sac devoid of muscular fibers [16]. When the defect is
located on the left side, the thorax may contain small
and large bowel, the spleen, the stomach, the left lobe of
the liver and, occasionally, the kidney. Right-sided CDHs
usually contain part of the right lobe of the liver and
sometimes the bowel and/or the kidney.
The lung is obviously hypoplastic on the side of the
hernia, but the contralateral one is also affected to a
variable extent. Lung weight is decreased and the num-
ber of alveoli is reduced due to insufficient branching
[61]. Respiratory epithelial maturity is delayed with hya-
line membrane disease patterns similar to those found
in prematures [62]. Surfactant deficiency has been
shown [63-65] although this issue is controversial [66].
The distal bronchiolar arteries have muscularized walls
and the wall thickness is increased particularly at the
expense of the media and adventitial layers [67,68].
The lung hypoplasia, immaturity and arteriolar thick-
ening that accompany human CDH can be due to pre-
natal compression of the lung by the herniated viscera.
All these lesions can be reproduced by surgically creat-
ing a CDH in rabbits [69-71] lambs [72-74] and pri-
mates [75]. These models were used for investigating
various aspects of CDH and also for developing fetal
surgery [76-81]. However, the associated malformations
are absent in these mechanical or surgical models and
this limits to some extent their validity as research tools.
In fact, the assumption that lung hypoplasia is purely
mechanical is probably incorrect because it is already
present in teratogenic models of CDH before any her-
niation has taken place. A “dual hit” pathogenesis [82],
in which abnormal development followed by
compression cause lung hypoplasia is widely accepted.
Regardless of the origin of the lung lesions, these consist
of insufficient airway branching [61,63,83], reduced gas
exchange surface, abnormal sacculo-alveolar maturation
[64,84] and abnormal, muscularized distal arterioles
[68,85].
Pharmacologic or teratogenic models of CDH have
been crucial for unveiling some pathogenic mechanisms.
Prenatal administration of oxidant chemicals like the
herbicide nitrofen (2,4-dichloro-phenyl-p-nitrophenyl
ether), 4-biphenyl carboxylic acid, bisdiamine, and SB-
210661, induce CDH in rodent fetuses. These chemicals
inhibit in vitro retinol-dehydrogenase-2 (RALDH-2) a
key enzyme for the production of retinoic acid (RA)
[86]. Among these agents, nitrofen has been the more
extensively used [54-56,87-97] because of the striking
resemblance of the diaphragmatic, pulmonary and other
associated defects to those of the human condition (Fig-
ure 2). Proliferation of the pleuroperitoneal folds is
arrested in rats with CDH [98] and the timing of this
arrest probably conditions the laterality of the defect.
Fibroblast growth factor (FGF) receptor-like 1 (FGFRL1)
[99] and WT1 [97] are downregulated in these
diaphragms.
Figure 2 Experimental CDH in rats. Administration of 100 mg of
the herbicide nitrofen on gestational day 9.5 to pregnant rats
induced the malformation in 40 to 80% of the offspring. On the left,
neonatal autopsy of an untreated, wild-type rat shows an intact
diaphragm (above) that can also be seen in the frontal section of
the trunk (below). On the right, similar preparations of a rat with
nitrofen-induced CDH show a large postero-lateral diaphragmatic
orifice, herniation of the liver into the thorax, displacement of the
mediastinum to the contralateral side and lung hypoplasia.
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Although the mechanism by which CDH is induced in
these models is not well known, disturbances of the reti-
noid signalling pathway, a key regulator of embryonic
morphogenesis, are likely [90]. Vitamin A deficient-rats
give birth to pups with CDH [100]. RA metabolism per-
turbations caused by nitrofen can be alleviated by addi-
tion of either vitamin A or RA [95,101-103].
Hypoplastic lungs from rats with nitrofen-induced CDH
show decreased RA synthesis [104] and deficient retinol
transportation [105], whereas RA rescues lung hypopla-
sia [93] probably by upregulating COUP-TFII, FOG2,
and GATA4 [106] that are known to be necessary for
both pulmonary and diaphragmatic development
[39,50]. On the other hand, compound knock-out mice
for retinoic acid receptors (RAR) have phenotypes invol-
ving CDH and several of the associated malformations
seen in this condition [107] whereas blockade of RAR
with BMS493 induces CDH [108] and administration of
BMS-189453, a RA antagonist, to pregnant mice repro-
duces the phenotype of CDH [109].
A similar involvement of the retinoid signaling path-
way is likely in human CDH because retinol and retinol-
binding protein were decreased in the blood of a group
of newborns with this malformation [110]. This has
recently been confirmed in a larger case-control study
[111]. Moreover, some of the genes involved in the
pathogenesis of human CDH are tightly related to reti-
noid signaling [112-115].
Another factor that might contribute to lung hypopla-
sia in CDH is decreased airway pressure during fetal life.
Fetuses with tracheal atresia have large lungs [116,117]
whereas fetal tracheostomy induces lung hypoplasia
[118]. It has been shown that airway peristalsis is abnor-
mal in lung explants from rat embryos treated with
nitrofen and it is likely that decreased airway pressure
could contribute to hypoplasia [92,119].
Diagnosis
As mentioned before, CDH is often ultrasonographically
diagnosed before birth [120,121]. The intestine and/or
the liver may be in the thorax and the lungs are small.
US scan allows detailed assessment of the heart. Lung
growth is measured as a proportion of head growth.
This lung-to-head ratio (LHR) has some prognostic
value [122-127] because when it is below 1, survival is
compromised [125,128,129]. However, the accuracy of
these measurements is questionable [130] and other
alternatives like lung/thorax (L/T) transverse area ratio
[126,131] or volumetry by MRI have been developed
[132-136]. The observed-to-expected LHR (o/e LHR)
seems to be a reliable predictor of severity (patch
requirement, ECMO) and survival [127,137]. The posi-
tion of the liver is also of unquestionable value, since
liver-up cases more often require ECMO support and
have worse survival [138-140]. The intra-thoracic posi-
tion of the stomach has less value for this purpose
[141,142]. When diagnosis is made in utero, amniocent-
esis is often performed for detecting chromosomal aber-
rations [143] and may help to estimate lung maturity
[64].
After birth, the diagnosis is readily made on the basis
of symptoms and physical signs. A plain X-ray of the
thorax and abdomen informs of the position of the her-
niated viscera. Blood gases and pH status reflect the effi-
ciency of gas exchange and other derived indexes refine
this assessment [144,145]. Ultrasonography of the heart
is necessary for ruling-out associated malformations, for
measuring the right-to-left shunt and for estimating the
severity of pulmonary hypertension [146-148]. Measure-
ments of the pulmonary artery diameters and the use of
some indexes derived from them may facilitate this task
[149-151]. Cardiac U.S. is one of the more reliable
methods for determining when the patient is
“stabilized”.
Differential diagnosis
It is rarely necessary to rule out other conditions
because CDH is often detected before birth and because
diagnosis is easy. Physical exam may suffice but passing
a naso-gastric catheter into the stomach before a plain
X-ray of the thorax and abdomen may help to locate it
or to detect esophageal displacement. In some rare
instances, X-rays may suggest a cystic malformation of
the lung but again the position of the stomach and the
contour of the intra-abdominal gas bubbles facilitate dis-
tinction of both conditions.
Treatment before birth
Since the introduction of routine prenatal U.S. screen-
ing, a large proportion of fetuses with CDH are diag-
nosed in utero. Termination of gestation is sometimes
preferred, particularly when chromosomal aberrations
and syndromes are present [5,152-154]. The possibility
of fetal instrumentation directed to alleviate the conse-
quences of the herniation is becoming a progressively
more acceptable alternative. Thirty years ago Harrison
and coll. started pioneer work in San Francisco aimed at
developing animal models of CDH on which to test the
effects of prenatal manipulation. After demonstrating in
fetal lambs that lung compression led to lung hypoplasia
[73] and that prenatal decompression reversed this con-
dition [72], this group undertook the surgical creation of
CDH [74] and later on, the demonstration of reversal of
lung hypoplasia and arteriolar thickening when the dia-
phragmatic defect was repaired before birth [155]. Clini-
cal application of this rationale led, with close
consideration of all the ethical and technical issues
involved, to the first attempts at prenatal repair of CDH
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in human fetuses [120,156,157]. The position of the fetal
liver [138] and the demonstration of the lethal effect of
umbilical vein compression during fetal reduction of the
left lobe of the liver into the abdomen during surgery
[74], limited considerably the number of cases suitable
for this approach. Furthermore, a randomized study
demonstrated that fetal repair did not produce better
outcomes than optimal postnatal treatment [158]. The
trial was discontinued and a new approach, based on
the observation of lung hyperplasia in congenital tra-
cheal obstruction, was developed. The evidence that air-
way pressure had something to do with lung
development led to assume that tracheal occlusion dur-
ing fetal life could counteract the effects of lung com-
pression in fetuses with CDH. This was tested in the
fetal lamb [77,78,159-161] and then in the human fetus
[162,163]. Another randomized trial was discontinued
when a significant shortening of gestation was observed
in fetuses treated in this manner [164]. However, the
effects of tracheal occlusion were indeed very positive in
terms of alveolar size and histology [159]. Maturation
and surfactant function were apparently not so much
improved, unless the plug was reversed before delivery
[165].
The concurrent development of minimally invasive
surgery had the immediate effect of making fetendo-
scopic balloon tracheal occlusion possible [75,163]. Con-
siderable experience rapidly accumulated and
randomized trials are currently underway concentrating
these efforts in fetuses with LHR below 1 considered
otherwise unviable [166]. Survivals approaching 50% in
this group are encouraging [139] and much information
has already accumulated on the structure, maturity and
tracheal pathology of survivors.
Experimental and clinical evidence suggest that bio-
chemical lung maturation is delayed in fetuses with
CDH [65,167-169] and this led to the proposal that this
process be accelerated by administration of maternal
corticosteroids as it is done for premature deliveries.
The evidence of the benefits of this medication is not
totally convincing [170,171] and therefore, a multicenter
trial could be necessary [172].
Treatment after birth
Whenever prenatal diagnosis is made, it is advisable to
direct the mother to a tertiary perinatal center in which
all the necessary obstetric, neonatal and surgical skills
are concentrated [173]. Gestation should be prolonged
until near term if possible [174] (this can be hard to
achieve in cases with polyhydramnios) and, although it
is often preferred [175], there is no evidence of the ben-
efits of delivery by Cesarean section [174,176,177].
When CDH becomes symptomatic after birth and in
all cases diagnosed prenatally, a careful protocol of
respiratory assistance should be implemented. Immedi-
ate postnatal intubation avoiding mask ventilation
should be carried out, and small-volume, high frequency
and reduced peak pressure mechanical ventilation
should be started. Oxygen delivery has to be tailored for
maintaining pre-established gasometric goals. Surfactant
has been used in an attempt to compensate for bio-
chemical immaturity in CDH babies [178,179], but this
has not been beneficial [180,181]. The stomach is emp-
tied through a nasogastric tube and vascular accesses
(peripheral and central veins, umbilical artery) are
secured for infusion of fluids, drug administration and
blood sampling. A bladder catheter is inserted and urine
output is monitored. Then, a period of assessment of
the chances of adequate gas exchange is started adapting
all actions to the clinical findings. If arterial oxygenation
is maintained above a preset minimum, the lung will
probably be capable of adequate gas exchange. Pre-duc-
tal and post-ductal percutaneous oxygen saturation mea-
surements help in the assessment of both the adequacy
of the lungs to sustain life and of the magnitude of
right-to-left shunting. Inotropic drugs are used as neces-
sary and cardiac function and heart anomalies are care-
fully evaluated. Persistent pulmonary hypertension may
cause right ventricle dysfunction and in these cases,
maintenance of the patency of the ductus arteriosus is
indicated [182].
After years of frustrating results of application of
respiratory assistance goals usually applied to other con-
ditions, it was realized that the hypoplastic and probably
immature lung of CDH was severely damaged by exces-
sive oxygen delivery and, particularly by excessive airway
pressure that led to pneumothorax, barotrauma and
volutrauma [183,184]. Mortality decreased drastically
and all these untoward consequences of ventilator assis-
tance became milder when a policy of “gentle ventila-
tion” was implemented [185]. Spontaneous ventilation
when possible or high frequency, low pressure ventila-
tion (< 20-25 cm H2O), no relaxation, alkalinisation and
adoption of modest gasometric goals (pre-ductal satura-
tion of 80-95%, PaO2 around 60 mmHg and “permis-
sive” hypercapnia of up to 60 mmHg) drastically
changed the results [186]. This policy progressively
gained adepts and it is nowadays the standard in most
developed countries [187-189].
High-frequency, oscillatory ventilation is also widely
used in these patients [190-192] in whom it allows ade-
quate oxygenation and CO2 elimination with very low
airway pressures [193]. Lung damage is apparently mini-
mized while attaining the modest gasometric objectives
set. A multicenter European trial is currently underway
[194].
For how long time these treatments are necessary var-
ies widely from one patient to another depending on the
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degree of lung hypoplasia, on the arteriolar reactivity
and therefore on the duration of persistent pulmonary
hypertension and on the associated malformations, par-
ticularly the cardiovascular ones.
The treatment of pulmonary hypertension is of parti-
cular concern because it determines shunting of non-
oxygenated blood out of the lungs. Several medications
have been used: tolazoline [67,195,196] and prostacy-
clins [197,198] were tried first but they did not produce
good enough results. Prostaglandin 1E is occasionally
used [199]. Inhaled nitric oxide, a well known smooth
muscle relaxant is, in turn, widely used [200-203] with
variable results although there is no strong evidence of
its benefits [204]. Inhibitors of phospho-diesterase like
sildenafil, known for their vasodilator action, are cur-
rently used in some cases [205] but, again, there is only
anecdotal evidence of their benefits. These medications
are coupled with inotropic agents, like dobutamine (up
to 20 mg/kg/min), dopamine (< 10 mg/kg/min) [206]
and also, sometimes with peripheral vasoconstrictors,
like adrenaline at low doses, aimed at reducing the
shunting by increasing pressure in the systemic
circulation.
ECMO
Extra-corporeal membrane oxygenation (ECMO) may be
a useful adjunct in the treatment of CDH. Cannulation
of both the right carotid artery and jugular vein and
connection to a circuit with a membrane gas exchange
chamber allows oxygenation and CO2 disposal without
participation of the lung which is preserved from any
pressure insult [207]. Alternatively, veno-venous ECMO
avoids cannulation of the carotid artery while permitting
adequate gas exchange [208-210].
ECMO can be seen as a safety net maintained until
proper gas exchange is demonstrated at weaning test
periods. The fact that institutions, particularly in the US,
which used ECMO liberally [10] had results comparable
to Canadian institutions [211] that rarely, if ever, used
it, casted some doubt on the actual need for this com-
plicated and risky procedure [12,212]. The criteria for
ECMO indication are variable, but they can be summar-
ized as follows: Inability to reach pre-ductal SatO2 >
85% or post-ductal SatO2 > 70%, oxygenation index
(mean airway pressure × FiO2 × 100/PaO2) ≥ 40 or
need for high peak inspiratory pressures or a-AdO2
greater than 600 for 6 to 8 hours [213]. The main con-
traindication is, of course, the inability to obtain SatO2
> 80% at any moment of the initial treatment under
FiO2 of 1. In fact, ECMO registries showed that the
worst results were obtained precisely in the CDH group
of patients [214,215]. This, together with the limitations
of the technique (required weight above 2000 g, need
for heparinisation), somewhat tempered the initial
enthusiasm and the proportion of patients so treated
decreased everywhere to more reasonable figures. There
is only weak evidence of the benefits of ECMO in this
particular group of patients [216] because only non-ran-
domized trials have been carried out on them [171,212]
and the only RCT reported in the UK was not specifi-
cally directed to babies with CDH [217]. This technique
is probably a good adjunct in a limited number of
patients in which predicted severe lung hypoplasia
would make adequate gas exchange impossible or in
those in whom reversal to the fetal pattern of circulation
becomes unmanageable.
Surgical repair
Surgical repair of CDH used to be in the past a life-sav-
ing emergency. It is presently accepted that it should be
undertaken only after cardio-respiratory functions are
stable. A policy of “delayed” surgery coupled with gentle
ventilation and occasionally ECMO support yields the
best results recorded. For how long surgery has to be
delayed is unclear, but a few days and even weeks may
be beneficial. The goal of all preoperative treatments is
to obtain “stabilization” of the patient and this means
acceptable oxygenation (PaO2 > 40 mmHg) and CO2
disposal (PaCO2 < 60 mmHg) with stable pulmonary
pressures (< 50% of systemic pressure), tolerable shunt-
ing, good myocardial function and adequate renal clear-
ance with reduced or withdrawn inotropic drugs.
Obviously, there are no magic indicators of stabilization
(this may also be impossible) and a decision to operate
is only made after a consensus among all the actors of
these treatments has been reached. Once again, when
critically reviewed, even the alleged benefits of delayed
repair are not consistently documented [218].
In many institutions, the operation is carried out in
the neonatal ICU in order to minimize changes that
might increase stress [219-221]. Under general anesthe-
sia, a subcostal or transverse abdominal incision is
made, the herniated viscera are carefully reduced into
the abdomen and the diaphragmatic orifice is closed
with interrupted sutures without leaving an intercostal
tube. A tube was routinely used in the past [58,222]
until it was realized that underwater seals cause
increased respiratory work and overdistension of the
hypoplastic lung that may further reduce ventilation. A
tubeless policy was then advised [185,223]. When the
defect is too large, a prosthetic patch is used to achieve
closure [224,225]. It is sutured to the rims of the orifice
with interrupted sutures and, to avoid excessive tension
and enlargement of the hemi-thorax, cone-shaping of
the patch can be beneficial [226]. The use of a patch
seems to increase the risk of re-herniation [227-230]
although it should be acknowledged that patients requir-
ing a patch have larger defects which entail higher
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morbidity [59]. Abdominal wall or latissimus dorsi mus-
cle flaps have also been used for CDH repair [231-234].
Malrotation or non-rotation is usually present but this
is rarely a problem in the newborn and the main con-
cern of the surgeon after repair of the hernia is abdom-
inal wall closure without excessive pressure [235,236]. In
some cases, another abdominal wall prosthetic patch is
necessary to avoid abdominal compartment syndrome
[237-239].
Since the advent of minimally invasive surgery (MIS),
thoracoscopic [240-246] or laparoscopic [247]
approaches have been proposed for CDH repair. Both
are indeed possible (with or without patch insertion),
although it should never be disregarded that this repair
comes only after stable conditions have been secured.
Probably, MIS is a good approach in cases diagnosed
during infancy or in outborns with less severe symp-
toms. Nevertheless, some concerns about this particular
approach in the newborn period have been expressed on
the basis of excessive perioperative hypercapnia and pro-
longed postoperative low brain oxygenation [248]. The
risk of recurrence after a minimally invasive approach
has been found to be similar to that of open surgery by
some reports [246] but it was indeed increased in other
series [248,249].
Prognosis
The main outcome endpoint is, of course, survival and
the wide range of figures reported is puzzling. When only
hospital, postoperative results were reported, survival
approached 70% [250] or more [189,251,252]. However,
those institutions with attached maternity facilities that
treated mostly inborns, reported higher mortalities. The
introduction of ECMO, in parallel with advances in other
aspects of treatment, improved the results and the top
institutions reported survivals approaching 90% although,
sometimes, their statistics excluded chromosomal aberra-
tions, multiple malformations and even some patients
that did not reach surgery. The truth is that still nowa-
days, if terminations of pregnancy, spontaneous abor-
tions, stillborns, pre-hospital and/or preoperative deaths
and surgical mortality are taken into account, real mor-
tality is still between 50% and 60%. But if only hospital
statistics are considered, there has been indeed a clearcut
progress in the results. Many institutions and the multi-
institutional registries report 70% to 80% survival with
some institutions peaking at 90%. Right-sided hernias
seem to have a worse prognosis than left-sided ones and
may require more ECMO support [253-255].
Other in-hospital complications can occur after CDH
repair. Pleural effusions and chylothorax may require
nutritional treatment, medication and drainage
[256-260].
Chronic respiratory tract disease is frequent in these
patients. Lung hypoplasia can be caught up only in part
during the first months of life and oxygen toxicity, baro-
trauma and volutrauma may occur even after gentle
ventilation. True broncho-pulmonary dysplasia is rela-
tively frequent in survivors [250,261], and a number of
them require oxygen at home for long periods of time
[228,251]. Restrictive [262-264] and obstructive
[263-265] lung diseases have been reported in CDH sur-
vivors many years after operation and diaphragmatic
rigidity and thoracic deformities can also play a minor
role in chronic lung disease [266-268].
Gastroesophageal reflux is frequent in CDH survi-
vors. The diaphragmatic sling may be malformed or
absent and the repair changes the anatomy of the
region. In addition, mal-rotation may delay gastric
emptying, and the abnormal balance of pressures in
the thorax and abdomen in the course of the respira-
tory cycle facilitates retrograde passage of gastric con-
tents to the esophagus [269]. Finally, there is evidence
of abnormal enteric innervation in CDH and it is likely
for esophago-gastric peristalsis to be abnormal
[96,270]. Reflux can complicate the pre-existing
respiratory disease and, for all these reasons, a consid-
erable proportion of these patients [271,272] respond
poorly to medical treatment and ultimately require
anti-reflux surgery [227,273-276]. Prophylactic fun-
doplication during surgical repair has been proposed in
patients with CDH [277]
Neurodevelopmental deficits are always possible in
these patients in whom brain oxygenation was marginal
for long periods of time and particularly when ECMO
required major vascular occlusion [228,278-283]. Neuro-
sensorial deafness occurs in a small proportion of chil-
dren surviving CDH [283-290]. This is progressive
[287,291] and it is generally considered to be accounted
for by prolonged antibiotic treatments [288]. However,
other newborns with similar treatments suffer this deaf-
ness more rarely and it should be acknowledged that
perhaps CDH patients have a particular sensitivity or a
developmental defect of the inner ear.
Other sequelae are possible in this particular group of
patients. This, and the frequent associated malforma-
tions, require long-term follow-up and permanent
support.
Genetic counseling
Most cases are sporadic but there are some reports of
familial clusters that suggest multifactoral [292-296]
rather than autosomal recessive [297,298] patterns of
inheritance. Genetic aspects of CDH were recently
addressed [299-302]. Two thirds of these cases were
males and the risk of recurrence in sibs is 2% [294].
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Unresolved questions
CDH remains one of the most difficult problems of
perinatology and neonatal surgery. Its mechanisms are
beginning to be unveiled, but the severity of the lung
and other lesions require the use of the entire arma-
mentarium of sophisticated neonatal care. This, together
with the rarity of the condition, make the setting of
solid evidence-based protocols of management very dif-
ficult. The perspectives of fetal manipulation or even of
prophylactic drug treatment remain still at an embryo-
nal stage and, most probably, this condition will remain
a hot topic of research in the coming years.
Conclusions
CDH is a complex condition probably caused by dis-
turbed molecular signaling during organogenesis. The
diaphragmatic orifice is invariably accompanied by pul-
monary hypoplasia with vascular hyper-reactivity that
causes deficient gas exchange and persistent pulmonary
hypertension. In addition, other malformations that
further complicate the clinical course may be present.
All efforts are directed at enhancing antenatal lung
growth in prenatally diagnosed cases and at protecting
the lung during the intensive care pre and post-opera-
tive phases in all cases. Fetoscopic reversible tracheal
obstruction seems promising before birth and gentle
ventilation with occasional ECMO use yields the best
results post-natally. Nevertheless, many aspects of the
disease are still unknown and, given that the incidence
is relatively high, that the expenses involved in the cur-
rent treatments are overwhelming and that the sequelae
are frequent, more research efforts into causation, pre-
vention and treatment are warranted.
Competing interests
The author declares that they have no competing interests.
Received: 24 March 2011 Accepted: 3 January 2012
Published: 3 January 2012
References
1. Irish MS, Holm BA, Glick PL: Congenital diaphragmatic hernia. A historical
review. Clin Perinatol 1996, 23:625-653.
2. Golombek SG: The history of congenital diaphragmatic hernia from
1850s to the present. J Perinatol 2002, 22:242-246.
3. McNamara JJ, Eraklis AJ, Gross RE: Congenital posterolateral diaphragmatic
hernia in the newborn. J Thorac Cardiovasc Surg 1968, 55:55-59.
4. Harrison MR, Bjordal RI, Langmark F, Knutrud O: Congenital diaphragmatic
hernia: the hidden mortality. J Pediatr Surg 1978, 13:227-230.
5. Stege G, Fenton A, Jaffray B: Nihilism in the 1990s: the true mortality of
congenital diaphragmatic hernia. Pediatrics 2003, 112:532-535.
6. Gallot D, Boda C, Ughetto S, Perthus I, Robert-Gnansia E, Francannet C,
Laurichesse-Delmas H, Jani J, Coste K, Deprest J, et al: Prenatal detection
and outcome of congenital diaphragmatic hernia: a French registry-
based study. Ultrasound Obstet Gynecol 2007, 29:276-283.
7. Torfs CP, Curry CJ, Bateson TF, Honore LH: A population-based study of
congenital diaphragmatic hernia. Teratology 1992, 46:555-565.
8. Yang W, Carmichael SL, Harris JA, Shaw GM: Epidemiologic characteristics
of congenital diaphragmatic hernia among 2.5 million California births,
1989-1997. Birth Defects Res A Clin Mol Teratol 2006, 76:170-174.
9. Sinha CK, Islam S, Patel S, Nicolaides K, Greenough A, Davenport M:
Congenital diaphragmatic hernia: prognostic indices in the fetal
endoluminal tracheal occlusion era. J Pediatr Surg 2009, 44:312-316.
10. Wilson JM, Lund DP, Lillehei CW, Vacanti JP: Congenital diaphragmatic
hernia–a tale of two cities: the Boston experience. J Pediatr Surg 1997,
32:401-405.
11. Bedoyan JK, Blackwell SC, Treadwell MC, Johnson A, Klein MD: Congenital
diaphragmatic hernia: associated anomalies and antenatal diagnosis.
Outcome-related variables at two Detroit hospitals. Pediatr Surg Int 2004,
20:170-176.
12. de Buys Roessingh AS, Dinh-Xuan AT: Congenital diaphragmatic hernia:
current status and review of the literature. Eur J Pediatr 2009,
168:393-406.
13. Keijzer R, Puri P: Congenital diaphragmatic hernia. Semin Pediatr Surg
2010, 19:180-185.
14. Johnston PW, Liberman R, Gangitano E, Vogt J: Ventilation parameters and
arterial blood gases as a prediction of hypoplasia in congenital
diaphragmatic hernia. J Pediatr Surg 1990, 25:496-499.
15. Elhalaby EA, Abo Sikeena MH: Delayed presentation of congenital
diaphragmatic hernia. Pediatr Surg Int 2002, 18:480-485.
16. Numanoglu A, Steiner Z, Millar A, Cywes S: Delayed presentation of
congenital diaphragmatic hernia. S Afr J Surg 1997, 35:74-76.
17. Stoll C, Alembik Y, Dott B, Roth MP: Associated malformations in cases
with congenital diaphragmatic hernia. Genet Couns 2008, 19:331-339.
18. Sweed Y, Puri P: Congenital diaphragmatic hernia: influence of
associated malformations on survival. Arch Dis Child 1993, 69:68-70.
19. Migliazza L, Otten C, Xia H, Rodriguez JI, Diez-Pardo JA, Tovar JA:
Cardiovascular malformations in congenital diaphragmatic hernia:
human and experimental studies. J Pediatr Surg 1999, 34:1352-1358.
20. Lin AE, Pober BR, Adatia I: Congenital diaphragmatic hernia and
associated cardiovascular malformations: type, frequency, and impact on
management. Am J Med Genet C Semin Med Genet 2007, 145C:201-216.
21. Siebert JR, Haas JE, Beckwith JB: Left ventricular hypoplasia in congenital
diaphragmatic hernia. J Pediatr Surg 1984, 19:567-571.
22. Baumgart S, Paul JJ, Huhta JC: Left heart hypoplasia in neonates having
congenital diaphragmatic hernia and treated with ECMO. J Pediatr Surg
1998, 33:1848.
23. Bollmann R, Kalache K, Mau H, Chaoui R, Tennstedt C: Associated
malformations and chromosomal defects in congenital diaphragmatic
hernia. Fetal Diagn Ther 1995, 10:52-59.
24. Migliazza L, Xia H, Diez-Pardo JA, Tovar JA: Skeletal malformations
associated with congenital diaphragmatic hernia: experimental and
human studies. J Pediatr Surg 1999, 34:1624-1629.
25. van Dooren MF, Goemaere NN, de Klein A, Tibboel D, de Krijger RR:
Postmortem findings and clinicopathological correlation in congenital
diaphragmatic hernia. Pediatr Dev Pathol 2004, 7:459-467.
26. Sabharwal AJ, Davis CF, Howatson AG: Post-mortem findings in fetal and
neonatal congenital diaphragmatic hernia. Eur J Pediatr Surg 2000,
10:96-99.
27. Brownlee EM, Howatson AG, Davis CF, Sabharwal AJ: The hidden mortality
of congenital diaphragmatic hernia: a 20-year review. J Pediatr Surg 2009,
44:317-320.
28. Slavotinek AM: Fryns syndrome: a review of the phenotype and
diagnostic guidelines. Am J Med Genet A 2004, 124A:427-433.
29. Scott DA, Cooper ML, Stankiewicz P, Patel A, Potocki L, Cheung SW:
Congenital diaphragmatic hernia in WAGR syndrome. Am J Med Genet A
2005, 134:430-433.
30. Luis AL, Pederiva F, Encinas JL, Ruiz E, Rodriguez JI, Martinez L, Tovar JA:
Parafollicular C-Cells of the Thyroid are Decreased in Patients with
Congenital Diaphragmatic Hernia. Eur J Pediatr Surg 2011, 21:246-249.
31. Pederiva F, Rodriguez JI, Ruiz-Bravo E, Martinez L, Tovar JA: Abnormal
intrinsic esophageal innervation in congenital diaphragmatic hernia: a
likely cause of motor dysfunction. J Pediatr Surg 2009, 44:496-499.
32. Baoquan Q, Diez-Pardo JA, Tovar JA: Intestinal rotation in experimental
congenital diaphragmatic hernia. J Pediatr Surg 1995, 30:1457-1462.
33. Ford EG, Senac MO Jr, Srikanth MS, Weitzman JJ: Malrotation of the
intestine in children. Ann Surg 1992, 215:172-178.
Tovar Orphanet Journal of Rare Diseases 2012, 7:1
http://www.ojrd.com/content/7/1/1
Page 8 of 15
34. Zaiss I, Kehl S, Link K, Neff W, Schaible T, Sutterlin M, Siemer J: Associated
Malformations in Congenital Diaphragmatic Hernia. Am J Perinatol 2010.
35. McPherson EW, Ketterer DM, Salsburey DJ: Pallister-Killian and Fryns
syndromes: nosology. Am J Med Genet 1993, 47:241-245.
36. Franceschini P, Guala A, Licata D, Botta G, Flora F, Angeli G, Di Cara G,
Franceschini D: Gershoni-Baruch syndrome: report of a new family
confirming autosomal recessive inheritance. Am J Med Genet A 2003,
122A:174-179.
37. Cho HY, Lee BS, Kang CH, Kim WH, Ha IS, Cheong HI, Choi Y: Hydrothorax
in a patient with Denys-Drash syndrome associated with a
diaphragmatic defect. Pediatr Nephrol 2006, 21:1909-1912.
38. Martinez-Frias ML, Bermejo E, Felix V, Jimenez N, Gomez-Ullate J, Lopez JA,
Aparicio P, Ayala A, Gairi JM, Galan E, et al: [Brachmann-de-Lange
syndrome in our population: clinical and epidemiological
characteristics]. An Esp Pediatr 1998, 48:293-298.
39. Kantarci S, Donahoe PK: Congenital diaphragmatic hernia (CDH) etiology
as revealed by pathway genetics. Am J Med Genet C Semin Med Genet
2007, 145C:217-226.
40. van Dooren MF, Brooks AS, Hoogeboom AJ, van den Hoonaard TL, de
Klein JE, Wouters CH, Tibboel D: Early diagnosis of Wolf-Hirschhorn
syndrome triggered by a life-threatening event: congenital
diaphragmatic hernia. Am J Med Genet A 2004, 127A:194-196.
41. Blancato JK, Hunt M, George J, Katz J, Meck JM: Prenatal diagnosis of
tetrasomy 12p by in situ hybridization: varying levels of mosaicism in
different fetal tissues. Prenat Diagn 1992, 12:979-983.
42. Klaassens M, Scott DA, van Dooren M, Hochstenbach R, Eussen HJ, Cai WW,
Galjaard RJ, Wouters C, Poot M, Laudy J, et al: Congenital diaphragmatic
hernia associated with duplication of 11q23-qter. Am J Med Genet A
2006, 140:1580-1586.
43. Schlembach D, Zenker M, Trautmann U, Ulmer R, Beinder E: Deletion
15q24-26 in prenatally detected diaphragmatic hernia: increasing
evidence of a candidate region for diaphragmatic development. Prenat
Diagn 2001, 21:289-292.
44. Biggio JR Jr, Descartes MD, Carroll AJ, Holt RL: Congenital diaphragmatic
hernia: is 15q26.1-26.2 a candidate locus? Am J Med Genet A 2004,
126A:183-185.
45. Kantarci S, Ackerman KG, Russell MK, Longoni M, Sougnez C, Noonan KM,
Hatchwell E, Zhang X, Pieretti Vanmarcke R, Anyane-Yeboa K, et al:
Characterization of the chromosome 1q41q42.12 region, and the
candidate gene DISP1, in patients with CDH. Am J Med Genet A 2010,
152A:2493-2504.
46. Wat MJ, Shchelochkov OA, Holder AM, Breman AM, Dagli A, Bacino C,
Scaglia F, Zori RT, Cheung SW, Scott DA, Kang SH: Chromosome 8p23.1
deletions as a cause of complex congenital heart defects and
diaphragmatic hernia. Am J Med Genet A 2009, 149A:1661-1677.
47. Kim PC, Mo R, Hui Cc C: Murine models of VACTERL syndrome: Role of
sonic hedgehog signaling pathway. J Pediatr Surg 2001, 36:381-384.
48. Liu J, Zhang L, Wang D, Shen H, Jiang M, Mei P, Hayden PS, Sedor JR,
Hu H: Congenital diaphragmatic hernia, kidney agenesis and cardiac
defects associated with Slit3-deficiency in mice. Mech Dev 2003,
120:1059-1070.
49. Yuan W, Rao Y, Babiuk RP, Greer JJ, Wu JY, Ornitz DM: A genetic model for
a central (septum transversum) congenital diaphragmatic hernia in mice
lacking Slit3. Proc Natl Acad Sci USA 2003, 100:5217-5222.
50. You LR, Takamoto N, Yu CT, Tanaka T, Kodama T, Demayo FJ, Tsai SY,
Tsai MJ: Mouse lacking COUP-TFII as an animal model of Bochdalek-type
congenital diaphragmatic hernia. Proc Natl Acad Sci USA 2005,
102:16351-16356.
51. Ackerman KG, Herron BJ, Vargas SO, Huang H, Tevosian SG, Kochilas L,
Rao C, Pober BR, Babiuk RP, Epstein JA, et al: Fog2 is required for normal
diaphragm and lung development in mice and humans. PLoS Genet
2005, 1:58-65.
52. Nordenskjold A, Tapper-Persson M, Anvret M: No evidence of WT1 gene
mutations in children with congenital diaphragmatic hernia. J Pediatr
Surg 1996, 31:925-927.
53. LopezJimenez N, Gerber S, Popovici V, Mirza S, Copren K, Ta L, Shaw GM,
Trueb B, Slavotinek AM: Examination of FGFRL1 as a candidate gene for
diaphragmatic defects at chromosome 4p16.3 shows that Fgfrl1 null
mice have reduced expression of Tpm3, sarcomere genes and Lrtm1 in
the diaphragm. Hum Genet 2009, 127:325-336.
54. Kluth D, Keijzer R, Hertl M, Tibboel D: Embryology of congenital
diaphragmatic hernia. Semin Pediatr Surg 1996, 5:224-233.
55. Allan DW, Greer JJ: Pathogenesis of nitrofen-induced congenital
diaphragmatic hernia in fetal rats. J Appl Physiol 1997, 83:338-347.
56. Greer JJ, Allan DW, Babiuk RP, Lemke RP: Recent advances in
understanding the pathogenesis of nitrofen-induced congenital
diaphragmatic hernia. Pediatr Pulmonol 2000, 29:394-399.
57. Babiuk RP, Zhang W, Clugston R, Allan DW, Greer JJ: Embryological origins
and development of the rat diaphragm. J Comp Neurol 2003, 455:477-487.
58. Clark RH, Hardin WD Jr, Hirschl RB, Jaksic T, Lally KP, Langham MR Jr,
Wilson JM: Current surgical management of congenital diaphragmatic
hernia: a report from the Congenital Diaphragmatic Hernia Study Group.
J Pediatr Surg 1998, 33:1004-1009.
59. Lally KP, Lally PA, Lasky RE, Tibboel D, Jaksic T, Wilson JM, Frenckner B, Van
Meurs KP, Bohn DJ, Davis CF, Hirschl RB: Defect size determines survival in
infants with congenital diaphragmatic hernia. Pediatrics 2007, 120:
e651-657.
60. Tsang TM, Tam PK, Dudley NE, Stevens J: Diaphragmatic agenesis as a
distinct clinical entity. J Pediatr Surg 1994, 29:1439-1441.
61. Schnitzer JJ: Control and regulation of pulmonary hypoplasia associated
with congenital diaphragmatic hernia. Semin Pediatr Surg 2004, 13:37-43.
62. George DK, Cooney TP, Chiu BK, Thurlbeck WM: Hypoplasia and
immaturity of the terminal lung unit (acinus) in congenital
diaphragmatic hernia. Am Rev Respir Dis 1987, 136:947-950.
63. Wigglesworth JS, Desai R, Guerrini P: Fetal lung hypoplasia: biochemical
and structural variations and their possible significance. Arch Dis Child
1981, 56:606-615.
64. Moya FR, Thomas VL, Romaguera J, Mysore MR, Maberry M, Bernard A,
Freund M: Fetal lung maturation in congenital diaphragmatic hernia. Am
J Obstet Gynecol 1995, 173:1401-1405.
65. Valls-i-Soler A, Alfonso LF, Arnaiz A, Alvarez FJ, Tovar JA: Pulmonary
surfactant dysfunction in congenital diaphragmatic hernia: experimental
and clinical findings. Biol Neonate 1996, 69:318-326.
66. Boucherat O, Benachi A, Chailley-Heu B, Franco-Montoya ML, Elie C,
Martinovic J, Bourbon JR: Surfactant maturation is not delayed in human
fetuses with diaphragmatic hernia. PLoS Med 2007, 4:e237.
67. Shochat SJ, Naeye RL, Ford WD, Whitman V, Maisels MJ: Congenital
diaphragmatic hernia. New concept in management. Ann Surg 1979,
190:332-341.
68. Yamataka T, Puri P: Pulmonary artery structural changes in pulmonary
hypertension complicating congenital diaphragmatic hernia. J Pediatr
Surg 1997, 32:387-390.
69. Ohi R, Suzuki H, Kato T, Kasai M: Development of the lung in fetal rabbits
with experimental diaphragmatic hernia. J Pediatr Surg 1976, 11:955-959.
70. Fauza DO, Tannuri U, Ayoub AA, Capelozzi VL, Saldiva PH, Maksoud JG:
Surgically produced congenital diaphragmatic hernia in fetal rabbits. J
Pediatr Surg 1994, 29:882-886.
71. Wu J, Yamamoto H, Gratacos E, Ge X, Verbeken E, Sueishi K, Hashimoto S,
Vanamo K, Lerut T, Deprest J: Lung development following diaphragmatic
hernia in the fetal rabbit. Hum Reprod 2000, 15:2483-2488.
72. Harrison MR, Bressack MA, Churg AM, de Lorimier AA: Correction of
congenital diaphragmatic hernia in utero. II. Simulated correction
permits fetal lung growth with survival at birth. Surgery 1980, 88:260-268.
73. Harrison MR, Jester JA, Ross NA: Correction of congenital diaphragmatic
hernia in utero. I. The model: intrathoracic balloon produces fatal
pulmonary hypoplasia. Surgery 1980, 88:174-182.
74. Harrison MR, Ross NA, de Lorimier AA: Correction of congenital
diaphragmatic hernia in utero. III. Development of a successful surgical
technique using abdominoplasty to avoid compromise of umbilical
blood flow. J Pediatr Surg 1981, 16:934-942.
75. Deprest JA, Lerut TE, Vandenberghe K: Operative fetoscopy: new
perspective in fetal therapy? Prenat Diagn 1997, 17:1247-1260.
76. Soper RT, Pringle KC, Scofield JC: Creation and repair of diaphragmatic
hernia in the fetal lamb: techniques and survival. J Pediatr Surg 1984,
19:33-40.
77. DiFiore JW, Fauza DO, Slavin R, Peters CA, Fackler JC, Wilson JM:
Experimental fetal tracheal ligation reverses the structural and
physiological effects of pulmonary hypoplasia in congenital
diaphragmatic hernia. J Pediatr Surg 1994, 29:248-256.
78. Hedrick MH, Estes JM, Sullivan KM, Bealer JF, Kitterman JA, Flake AW,
Adzick NS, Harrison MR: Plug the lung until it grows (PLUG): a new
Tovar Orphanet Journal of Rare Diseases 2012, 7:1
http://www.ojrd.com/content/7/1/1
Page 9 of 15
method to treat congenital diaphragmatic hernia in utero. J Pediatr Surg
1994, 29:612-617.
79. Benachi A, Dommergues M, Delezoide AL, Bourbon J, Dumez Y,
Brunnelle F: Tracheal obstruction in experimental diaphragmatic hernia:
an endoscopic approach in the fetal lamb. Prenat Diagn 1997, 17:629-634.
80. Luks FI, Wild YK, Piasecki GJ, De Paepe ME: Short-term tracheal occlusion
corrects pulmonary vascular anomalies in the fetal lamb with
diaphragmatic hernia. Surgery 2000, 128:266-272.
81. Bratu I, Flageole H, Laberge JM, Kovacs L, Faucher D, Piedboeuf B: Lung
function in lambs with diaphragmatic hernia after reversible fetal
tracheal occlusion. J Pediatr Surg 2004, 39:1524-1531.
82. Keijzer R, Liu J, Deimling J, Tibboel D, Post M: Dual-hit hypothesis explains
pulmonary hypoplasia in the nitrofen model of congenital
diaphragmatic hernia. Am J Pathol 2000, 156:1299-1306.
83. Nose K, Kamata S, Sawai T, Tazuke Y, Usui N, Kawahara H, Okada A: Airway
anomalies in patients with congenital diaphragmatic hernia. J Pediatr
Surg 2000, 35:1562-1565.
84. Alfonso LF, Arnaiz A, Alvarez FJ, Qi B, Diez-Pardo JA, Vallis-i-Soler A,
Tovar JA: Lung hypoplasia and surfactant system immaturity induced in
the fetal rat by prenatal exposure to nitrofen. Biol Neonate 1996,
69:94-100.
85. Geggel RL, Murphy JD, Langleben D, Crone RK, Vacanti JP, Reid LM:
Congenital diaphragmatic hernia: arterial structural changes and
persistent pulmonary hypertension after surgical repair. J Pediatr 1985,
107:457-464.
86. Mey J, Babiuk RP, Clugston R, Zhang W, Greer JJ: Retinal dehydrogenase-2
is inhibited by compounds that induce congenital diaphragmatic
hernias in rodents. Am J Pathol 2003, 162:673-679.
87. Kluth D, Kangah R, Reich P, Tenbrinck R, Tibboel D, Lambrecht W: Nitrofen-
induced diaphragmatic hernias in rats: an animal model. J Pediatr Surg
1990, 25:850-854.
88. Tenbrinck R, Tibboel D, Gaillard JL, Kluth D, Bos AP, Lachmann B,
Molenaar JC: Experimentally induced congenital diaphragmatic hernia in
rats. J Pediatr Surg 1990, 25:426-429.
89. Alfonso LF, Vilanova J, Aldazabal P, Lopez de Torre B, Tovar JA: Lung
growth and maturation in the rat model of experimentally induced
congenital diaphragmatic hernia. Eur J Pediatr Surg 1993, 3:6-11.
90. Greer JJ, Babiuk RP, Thebaud B: Etiology of congenital diaphragmatic
hernia: the retinoid hypothesis. Pediatr Res 2003, 53:726-730.
91. Van Tuyl M, Blommaart PE, Keijzer R, Wert SE, Ruijter JM, Lamers WH,
Tibboel D: Pulmonary surfactant protein A, B, and C mRNA and protein
expression in the nitrofen-induced congenital diaphragmatic hernia rat
model. Pediatr Res 2003, 54:641-652.
92. Jesudason EC, Smith NP, Connell MG, Spiller DG, White MR, Fernig DG,
Losty PD: Peristalsis of airway smooth muscle is developmentally
regulated and uncoupled from hypoplastic lung growth. Am J Physiol
Lung Cell Mol Physiol 2006, 291:L559-565.
93. Montedonico S, Nakazawa N, Puri P: Retinoic acid rescues lung hypoplasia
in nitrofen-induced hypoplastic foetal rat lung explants. Pediatr Surg Int
2006, 22:2-8.
94. Takayasu H, Nakazawa N, Montedonico S, Puri P: Reduced expression of
aquaporin 5 water channel in nitrofen-induced hypoplastic lung with
congenital diaphragmatic hernia rat model. J Pediatr Surg 2007,
42:415-419.
95. Montedonico S, Sugimoto K, Felle P, Bannigan J, Puri P: Prenatal treatment
with retinoic acid promotes pulmonary alveologenesis in the nitrofen
model of congenital diaphragmatic hernia. J Pediatr Surg 2008,
43:500-507.
96. Martinez L, Pederiva F, Martinez-Calonge W, Aras-Lopez R, Tovar JA: The
myenteric plexus of the esophagus is abnormal in an experimental
congenital diaphragmatic hernia model. Eur J Pediatr Surg 2009,
19:163-167.
97. Dingemann J, Doi T, Ruttenstock E, Puri P: Expression of the Wilm’s tumor
gene WT1 during diaphragmatic development in the nitrofen model for
congenital diaphragmatic hernia. Pediatr Surg Int 2010.
98. Clugston RD, Zhang W, Greer JJ: Early development of the primordial
mammalian diaphragm and cellular mechanisms of nitrofen-induced
congenital diaphragmatic hernia. Birth Defects Res A Clin Mol Teratol 2010,
88:15-24.
99. Dingemann J, Doi T, Ruttenstock EM, Puri P: Downregulation of FGFRL1
Contributes to the Development of the Diaphragmatic Defect in the
Nitrofen Model of Congenital Diaphragmatic Hernia. Eur J Pediatr Surg .
100. Andersen DH: Effect of diet during pregnancy upon the incidence of
congenital hereditary diaphragmatic hernia in the rat; failure to produce
cystic fibrosis of the pancreas by maternal vitamin A deficiency. Am J
Pathol 1949, 25:163-185.
101. Thebaud B, Tibboel D, Rambaud C, Mercier JC, Bourbon JR, Dinh-Xuan AT,
Archer SL: Vitamin A decreases the incidence and severity of nitrofen-
induced congenital diaphragmatic hernia in rats. Am J Physiol 1999, 277:
L423-429.
102. Thebaud B, Barlier-Mur AM, Chailley-Heu B, Henrion-Caude A, Tibboel D,
Dinh-Xuan AT, Bourbon JR: Restoring effects of vitamin A on surfactant
synthesis in nitrofen-induced congenital diaphragmatic hernia in rats.
Am J Respir Crit Care Med 2001, 164:1083-1089.
103. Babiuk RP, Thebaud B, Greer JJ: Reductions in the incidence of nitrofen-
induced diaphragmatic hernia by vitamin A and retinoic acid. Am J
Physiol Lung Cell Mol Physiol 2004, 286:L970-973.
104. Nakazawa N, Takayasu H, Montedonico S, Puri P: Altered regulation of
retinoic acid synthesis in nitrofen-induced hypoplastic lung. Pediatr Surg
Int 2007, 23:391-396.
105. Nakazawa N, Montedonico S, Takayasu H, Paradisi F, Puri P: Disturbance of
retinol transportation causes nitrofen-induced hypoplastic lung. J Pediatr
Surg 2007, 42:345-349.
106. Doi T, Sugimoto K, Puri P: Prenatal retinoic acid up-regulates pulmonary
gene expression of COUP-TFII, FOG2, and GATA4 in pulmonary
hypoplasia. J Pediatr Surg 2009, 44:1933-1937.
107. Mendelsohn C, Lohnes D, Decimo D, Lufkin T, LeMeur M, Chambon P,
Mark M: Function of the retinoic acid receptors (RARs) during
development (II). Multiple abnormalities at various stages of
organogenesis in RAR double mutants. Development 1994, 120:2749-2771.
108. Clugston RD, Zhang W, Alvarez S, de Lera AR, Greer JJ: Understanding
abnormal retinoid signaling as a causative mechanism in congenital
diaphragmatic hernia. Am J Respir Cell Mol Biol 2009, 42:276-285.
109. Cipollone D, Cozzi DA, Businaro R, Marino B: Congenital diaphragmatic
hernia after exposure to a triple retinoic acid antagonist during
pregnancy. J Cardiovasc Med (Hagerstown) 2010.
110. Major D, Cadenas M, Fournier L, Leclerc S, Lefebvre M, Cloutier R: Retinol
status of newborn infants with congenital diaphragmatic hernia. Pediatr
Surg Int 1998, 13:547-549.
111. Beurskens LW, Tibboel D, Lindemans J, Duvekot JJ, Cohen-Overbeek TE,
Veenma DC, de Klein A, Greer JJ, Steegers-Theunissen RP: Retinol status of
newborn infants is associated with congenital diaphragmatic hernia.
Pediatrics 2010, 126:712-720.
112. Goumy C, Gouas L, Marceau G, Coste K, Veronese L, Gallot D, Sapin V,
Vago P, Tchirkov A: Retinoid pathway and congenital diaphragmatic
hernia: hypothesis from the analysis of chromosomal abnormalities. Fetal
Diagn Ther 2010, 28:129-139.
113. Gallot D, Marceau G, Coste K, Hadden H, Robert-Gnansia E, Laurichesse H,
Dechelotte PJ, Labbe A, Dastugue B, Lemery D, Sapin V: Congenital
diaphragmatic hernia: a retinoid-signaling pathway disruption during
lung development? Birth Defects Res A Clin Mol Teratol 2005, 73:523-531.
114. Holder AM, Klaassens M, Tibboel D, de Klein A, Lee B, Scott DA: Genetic
factors in congenital diaphragmatic hernia. Am J Hum Genet 2007,
80:825-845.
115. Montedonico S, Nakazawa N, Puri P: Congenital diaphragmatic hernia and
retinoids: searching for an etiology. Pediatr Surg Int 2008, 24:755-761.
116. Kitano Y, Flake AW, Quinn TM, Kanai M, Davies P, Sablich TJ, Schneider C,
Adzick NS, von Allmen D: Lung growth induced by tracheal occlusion in
the sheep is augmented by airway pressurization. J Pediatr Surg 2000,
35:216-221.
117. Kitano Y, Kanai M, Davies P, von Allmen D, Yang EY, Radu A, Adzick NS,
Flake AW: BAPS prize-1999: Lung growth induced by prenatal tracheal
occlusion and its modifying factors: a study in the rat model of
congenital diaphragmatic hernia. J Pediatr Surg 2001, 36:251-259.
118. Fewell JE, Hislop AA, Kitterman JA, Johnson P: Effect of tracheostomy on
lung development in fetal lambs. J Appl Physiol 1983, 55:1103-1108.
119. Jesudason EC: Exploiting mechanical stimuli to rescue growth of the
hypoplastic lung. Pediatr Surg Int 2007, 23:827-836.
Tovar Orphanet Journal of Rare Diseases 2012, 7:1
http://www.ojrd.com/content/7/1/1
Page 10 of 15
120. Nakayama DK, Harrison MR, Chinn DH, Callen PW, Filly RA, Golbus MS, De
Lorimier AA: Prenatal diagnosis and natural history of the fetus with a
congenital diaphragmatic hernia: initial clinical experience. J Pediatr Surg
1985, 20:118-124.
121. Adzick NS, Vacanti JP, Lillehei CW, O’Rourke PP, Crone RK, Wilson JM: Fetal
diaphragmatic hernia: ultrasound diagnosis and clinical outcome in 38
cases. J Pediatr Surg 1989, 24:654-657.
122. Knox E, Lissauer D, Khan K, Kilby M: Prenatal detection of pulmonary
hypoplasia in fetuses with congenital diaphragmatic hernia: a systematic
review and meta-analysis of diagnostic studies. J Matern Fetal Neonatal
Med 2010, 23:579-588.
123. Sandaite I, Claus F, De Keyzer F, Done E, Van Mieghem T, Gucciardo L,
Dekoninck P, Jani J, Cannie M, Deprest JA: Examining the Relationship
between the Lung-to-Head Ratio Measured on Ultrasound and Lung
Volumetry by Magnetic Resonance in Fetuses with Isolated Congenital
Diaphragmatic Hernia. Fetal Diagn Ther 2010.
124. Harrison MR, Sydorak RM, Farrell JA, Kitterman JA, Filly RA, Albanese CT:
Fetoscopic temporary tracheal occlusion for congenital diaphragmatic
hernia: prelude to a randomized, controlled trial. J Pediatr Surg 2003,
38:1012-1020.
125. Jani J, Peralta CF, Van Schoubroeck D, Deprest J, Nicolaides KH:
Relationship between lung-to-head ratio and lung volume in normal
fetuses and fetuses with diaphragmatic hernia. Ultrasound Obstet Gynecol
2006, 27:545-550.
126. Usui N, Okuyama H, Sawai T, Kamiyama M, Kamata S, Fukuzawa M:
Relationship between L/T ratio and LHR in the prenatal assessment of
pulmonary hypoplasia in congenital diaphragmatic hernia. Pediatr Surg
Int 2007, 23:971-976.
127. Jani JC, Benachi A, Nicolaides KH, Allegaert K, Gratacos E, Mazkereth R,
Matis J, Tibboel D, Van Heijst A, Storme L, et al: Prenatal prediction of
neonatal morbidity in survivors with congenital diaphragmatic hernia: a
multicenter study. Ultrasound Obstet Gynecol 2009, 33:64-69.
128. Metkus AP, Filly RA, Stringer MD, Harrison MR, Adzick NS: Sonographic
predictors of survival in fetal diaphragmatic hernia. J Pediatr Surg 1996,
31:148-151.
129. Lipshutz GS, Albanese CT, Feldstein VA, Jennings RW, Housley HT, Beech R,
Farrell JA, Harrison MR: Prospective analysis of lung-to-head ratio predicts
survival for patients with prenatally diagnosed congenital diaphragmatic
hernia. J Pediatr Surg 1997, 32:1634-1636.
130. Heling KS, Wauer RR, Hammer H, Bollmann R, Chaoui R: Reliability of the
lung-to-head ratio in predicting outcome and neonatal ventilation
parameters in fetuses with congenital diaphragmatic hernia. Ultrasound
Obstet Gynecol 2005, 25:112-118.
131. Tsukimori K, Masumoto K, Morokuma S, Yoshimura T, Taguchi T, Hara T,
Sakaguchi Y, Takahashi S, Wake N, Suita S: The lung-to-thorax transverse
area ratio at term and near term correlates with survival in isolated
congenital diaphragmatic hernia. J Ultrasound Med 2008, 27:707-713.
132. Mahieu-Caputo D, Sonigo P, Dommergues M, Fournet JC, Thalabard JC,
Abarca C, Benachi A, Brunelle F, Dumez Y: Fetal lung volume
measurement by magnetic resonance imaging in congenital
diaphragmatic hernia. BJOG 2001, 108:863-868.
133. Gorincour G, Bouvenot J, Mourot MG, Sonigo P, Chaumoitre K, Garel C,
Guibaud L, Rypens F, Avni F, Cassart M, et al: Prenatal prognosis of
congenital diaphragmatic hernia using magnetic resonance imaging
measurement of fetal lung volume. Ultrasound Obstet Gynecol 2005,
26:738-744.
134. Jani J, Breysem L, Maes F, Boulvain M, Roubliova X, Lewi L, Vaast P,
Biard JM, Cannie M, Deprest J: Accuracy of magnetic resonance imaging
for measuring fetal sheep lungs and other organs. Ultrasound Obstet
Gynecol 2005, 25:270-276.
135. Cannie M, Jani JC, De Keyzer F, Devlieger R, Van Schoubroeck D, Witters I,
Marchal G, Dymarkowski S, Deprest JA: Fetal body volume: use at MR
imaging to quantify relative lung volume in fetuses suspected of having
pulmonary hypoplasia. Radiology 2006, 241:847-853.
136. Kilian AK, Schaible T, Hofmann V, Brade J, Neff KW, Busing KA: Congenital
diaphragmatic hernia: predictive value of MRI relative lung-to-head ratio
compared with MRI fetal lung volume and sonographic lung-to-head
ratio. Am J Roentgenol 2009, 192:153-158.
137. Done E, Gucciardo L, Van Mieghem T, Jani J, Cannie M, Van Schoubroeck D,
Devlieger R, Catte LD, Klaritsch P, Mayer S, et al: Prenatal diagnosis,
prediction of outcome and in utero therapy of isolated congenital
diaphragmatic hernia. Prenat Diagn 2008, 28:581-591.
138. Albanese CT, Lopoo J, Goldstein RB, Filly RA, Feldstein VA, Calen PW,
Jennings RW, Farrell JA, Harrison MR: Fetal liver position and perinatal
outcome for congenital diaphragmatic hernia. Prenat Diagn 1998,
18:1138-1142.
139. Deprest J, Jani J, Gratacos E, Vandecruys H, Naulaers G, Delgado J,
Greenough A, Nicolaides K: Fetal intervention for congenital
diaphragmatic hernia: the European experience. Semin Perinatol 2005,
29:94-103.
140. Hedrick HL, Danzer E, Merchant A, Bebbington MW, Zhao H, Flake AW,
Johnson MP, Liechty KW, Howell LJ, Wilson RD, Adzick NS: Liver position
and lung-to-head ratio for prediction of extracorporeal membrane
oxygenation and survival in isolated left congenital diaphragmatic
hernia. Am J Obstet Gynecol 2007, 197:422, e421-424.
141. Goodfellow T, Hyde I, Burge DM, Freeman NV: Congenital diaphragmatic
hernia: the prognostic significance of the site of the stomach. Br J Radiol
1987, 60:993-995.
142. Laudy JA, Van Gucht M, Van Dooren MF, Wladimiroff JW, Tibboel D:
Congenital diaphragmatic hernia: an evaluation of the prognostic value
of the lung-to-head ratio and other prenatal parameters. Prenat Diagn
2003, 23:634-639.
143. Takahashi H, Hayashi S, Miura Y, Tsukamoto K, Kosaki R, Itoh Y, Sago H:
Trisomy 9 mosaicism diagnosed in utero. Obstet Gynecol Int 2010.
144. Bohn D, Tamura M, Perrin D, Barker G, Rabinovitch M: Ventilatory
predictors of pulmonary hypoplasia in congenital diaphragmatic hernia,
confirmed by morphologic assessment. J Pediatr 1987, 111:423-431.
145. Wilson JM, Lund DP, Lillehei CW, Vacanti JP: Congenital diaphragmatic
hernia: predictors of severity in the ECMO era. J Pediatr Surg 1991,
26:1028-1033.
146. Haugen SE, Linker D, Eik-Nes S, Kufaas T, Vik T, Eggen BM, Brubakk AM:
Congenital diaphragmatic hernia: determination of the optimal time for
operation by echocardiographic monitoring of the pulmonary arterial
pressure. J Pediatr Surg 1991, 26:560-562.
147. Tanabe M, Yoshida H, Iwai J, Takahashi H, Ohnuma N, Terai M: Doppler
flow patterns through the ductus arteriosus in patients with congenital
diaphragmatic hernia. Eur J Pediatr Surg 2000, 10:92-95.
148. Okazaki T, Kohno S, Hasegawa S, Urushihara N, Yoshida A, Kawano S,
Saito A, Tanaka Y: Congenital diaphragmatic hernia: efficacy of
ultrasound examination in its management. Pediatr Surg Int 2003,
19:176-179.
149. Suda K, Bigras JL, Bohn D, Hornberger LK, McCrindle BW:
Echocardiographic predictors of outcome in newborns with congenital
diaphragmatic hernia. Pediatrics 2000, 105:1106-1109.
150. Takahashi S, Oishi Y, Ito N, Nanba Y, Tsukamoto K, Nakamura T, Ito Y,
Hayashi S, Sago H, Kuroda T, Honna T: Evaluating mortality and disease
severity in congenital diaphragmatic hernia using the McGoon and
pulmonary artery indices. J Pediatr Surg 2009, 44:2101-2106.
151. Okamoto S, Ikawa H, Fukumoto H, Masuyama H, Konuma K, Kohno M,
Nakamura T, Takahashi H: Patent ductus arteriosus flow patterns in the
treatment of congenital diaphragmatic hernia. Pediatr Int 2009,
51:555-558.
152. Garne E, Haeusler M, Barisic I, Gjergja R, Stoll C, Clementi M: Congenital
diaphragmatic hernia: evaluation of prenatal diagnosis in 20 European
regions. Ultrasound Obstet Gynecol 2002, 19:329-333.
153. Colvin J, Bower C, Dickinson JE, Sokol J: Outcomes of congenital
diaphragmatic hernia: a population-based study in Western Australia.
Pediatrics 2005, 116:e356-363.
154. Richmond S, Atkins J: A population-based study of the prenatal diagnosis
of congenital malformation over 16 years. BJOG 2005, 112:1349-1357.
155. Adzick NS, Outwater KM, Harrison MR, Davies P, Glick PL, deLorimier AA,
Reid LM: Correction of congenital diaphragmatic hernia in utero. IV. An
early gestational fetal lamb model for pulmonary vascular
morphometric analysis. J Pediatr Surg 1985, 20:673-680.
156. Harrison MR, Langer JC, Adzick NS, Golbus MS, Filly RA, Anderson RL,
Rosen MA, Callen PW, Goldstein RB, deLorimier AA: Correction of
congenital diaphragmatic hernia in utero, V. Initial clinical experience. J
Pediatr Surg 1990, 25:47-55.
157. Harrison MR, Adzick NS: The fetus as a patient. Surgical considerations.
Ann Surg 1991, 213:279-291.
Tovar Orphanet Journal of Rare Diseases 2012, 7:1
http://www.ojrd.com/content/7/1/1
Page 11 of 15
158. Harrison MR, Adzick NS, Bullard KM, Farrell JA, Howell LJ, Rosen MA, Sola A,
Goldberg JD, Filly RA: Correction of congenital diaphragmatic hernia in
utero VII: a prospective trial. J Pediatr Surg 1997, 32:1637-1642.
159. Harrison MR, Adzick NS, Flake AW, VanderWall KJ, Bealer JF, Howell LJ,
Farrell JA, Filly RA, Rosen MA, Sola A, Goldberg JD: Correction of
congenital diaphragmatic hernia in utero VIII: Response of the
hypoplastic lung to tracheal occlusion. J Pediatr Surg 1996, 31:1339-1348.
160. Skarsgard ED, Meuli M, VanderWall KJ, Bealer JF, Adzick NS, Harrison MR:
Fetal endoscopic tracheal occlusion (’Fetendo-PLUG’) for congenital
diaphragmatic hernia. J Pediatr Surg 1996, 31:1335-1338.
161. VanderWall KJ, Bruch SW, Meuli M, Kohl T, Szabo Z, Adzick NS, Harrison MR:
Fetal endoscopic (’Fetendo’) tracheal clip. J Pediatr Surg 1996,
31:1101-1103.
162. VanderWall KJ, Skarsgard ED, Filly RA, Eckert J, Harrison MR: Fetendo-clip: a
fetal endoscopic tracheal clip procedure in a human fetus. J Pediatr Surg
1997, 32:970-972.
163. Harrison MR, Mychaliska GB, Albanese CT, Jennings RW, Farrell JA,
Hawgood S, Sandberg P, Levine AH, Lobo E, Filly RA: Correction of
congenital diaphragmatic hernia in utero IX: fetuses with poor prognosis
(liver herniation and low lung-to-head ratio) can be saved by fetoscopic
temporary tracheal occlusion. J Pediatr Surg 1998, 33:1017-1022.
164. Harrison MR, Keller RL, Hawgood SB, Kitterman JA, Sandberg PL, Farmer DL,
Lee H, Filly RA, Farrell JA, Albanese CT: A randomized trial of fetal
endoscopic tracheal occlusion for severe fetal congenital diaphragmatic
hernia. N Engl J Med 2003, 349:1916-1924.
165. Flageole H, Evrard VA, Piedboeuf B, Laberge JM, Lerut TE, Deprest JA: The
plug-unplug sequence: an important step to achieve type II
pneumocyte maturation in the fetal lamb model. J Pediatr Surg 1998,
33:299-303.
166. Cannie MM, Jani JC, De Keyzer F, Allegaert K, Dymarkowski S, Deprest J:
Evidence and patterns in lung response after fetal tracheal occlusion:
clinical controlled study. Radiology 2009, 252:526-533.
167. Suen HC, Catlin EA, Ryan DP, Wain JC, Donahoe PK: Biochemical
immaturity of lungs in congenital diaphragmatic hernia. J Pediatr Surg
1993, 28:471-475.
168. Suen HC, Bloch KD, Donahoe PK: Antenatal glucocorticoid corrects
pulmonary immaturity in experimentally induced congenital
diaphragmatic hernia in rats. Pediatr Res 1994, 35:523-529.
169. Losty PD, Suen HC, Manganaro TF, Donahoe PK, Schnitzer JJ: Prenatal
hormonal therapy improves pulmonary compliance in the nitrofen-
induced CDH rat model. J Pediatr Surg 1995, 30:420-426.
170. Lally KP, Bagolan P, Hosie S, Lally PA, Stewart M, Cotten CM, Van Meurs KP,
Alexander G: Corticosteroids for fetuses with congenital diaphragmatic
hernia: can we show benefit? J Pediatr Surg 2006, 41:668-674.
171. Logan JW, Rice HE, Goldberg RN, Cotten CM: Congenital diaphragmatic
hernia: a systematic review and summary of best-evidence practice
strategies. J Perinatol 2007, 27:535-549.
172. Keijzer R, van Tuyl M, Tibboel D: Hormonal modulation of fetal pulmonary
development: relevance for the fetus with diaphragmatic hernia. Eur J
Obstet Gynecol Reprod Biol 2000, 92:127-133.
173. Shaw KS, Filiatrault D, Yazbeck S, St-Vil D: Improved survival for congenital
diaphragmatic hernia, based on prenatal ultrasound diagnosis and
referral to a combined obstetric-pediatric surgical center. J Pediatr Surg
1994, 29:1268-1269.
174. Stevens TP, van Wijngaarden E, Ackerman KG, Lally PA, Lally KP: Timing of
delivery and survival rates for infants with prenatal diagnoses of
congenital diaphragmatic hernia. Pediatrics 2009, 123:494-502.
175. Betremieux P, Gaillot T, de la Pintiere A, Beuchee A, Pasquier L,
Habonimana E, Le Bouar G, Branger B, Milon J, Fremond B, et al:
Congenital diaphragmatic hernia: prenatal diagnosis permits immediate
intensive care with high survival rate in isolated cases. A population-
based study. Prenat Diagn 2004, 24:487-493.
176. Frenckner BP, Lally PA, Hintz SR, Lally KP: Prenatal diagnosis of congenital
diaphragmatic hernia: how should the babies be delivered? J Pediatr
Surg 2007, 42:1533-1538.
177. Safavi A, Lin Y, Skarsgard ED: Perinatal management of congenital
diaphragmatic hernia: when and how should babies be delivered?
Results from the Canadian Pediatric Surgery Network. J Pediatr Surg 2010,
45:2334-2339.
178. Glick PL, Leach CL, Besner GE, Egan EA, Morin FC, Malanowska-Kantoch A,
Robinson LK, Brody A, Lele AS, McDonnell M, et al: Pathophysiology of
congenital diaphragmatic hernia. III: Exogenous surfactant therapy for
the high-risk neonate with CDH. J Pediatr Surg 1992, 27:866-869.
179. Bae CW, Jang CK, Chung SJ, Choi YM, Oh SM, Lee TS, Shin OY: Exogenous
pulmonary surfactant replacement therapy in a neonate with pulmonary
hypoplasia accompanying congenital diaphragmatic hernia–a case
report. J Korean Med Sci 1996, 11:265-270.
180. Colby CE, Lally KP, Hintz SR, Lally PA, Tibboel D, Moya FR, VanMeurs KP:
Surfactant replacement therapy on ECMO does not improve outcome in
neonates with congenital diaphragmatic hernia. J Pediatr Surg 2004,
39:1632-1637.
181. Van Meurs K: Is surfactant therapy beneficial in the treatment of the
term newborn infant with congenital diaphragmatic hernia? J Pediatr
2004, 145:312-316.
182. Mohseni-Bod H, Bohn D: Pulmonary hypertension in congenital
diaphragmatic hernia. Semin Pediatr Surg 2007, 16:126-133.
183. Sakurai Y, Azarow K, Cutz E, Messineo A, Pearl R, Bohn D: Pulmonary
barotrauma in congenital diaphragmatic hernia: a clinicopathological
correlation. J Pediatr Surg 1999, 34:1813-1817.
184. Langham MR Jr, Kays DW, Beierle EA, Chen MK, Mullet TC, Rieger K,
Wood CE, Talbert JL: Twenty years of progress in congenital
diaphragmatic hernia at the University of Florida. Am Surg 2003, 69:45-52.
185. Wung JT, Sahni R, Moffitt ST, Lipsitz E, Stolar CJ: Congenital diaphragmatic
hernia: survival treated with very delayed surgery, spontaneous
respiration, and no chest tube. J Pediatr Surg 1995, 30:406-409.
186. Boloker J, Bateman DA, Wung JT, Stolar CJ: Congenital diaphragmatic
hernia in 120 infants treated consecutively with permissive
hypercapnea/spontaneous respiration/elective repair. J Pediatr Surg 2002,
37:357-366.
187. Frenckner B, Ehren H, Granholm T, Linden V, Palmer K: Improved results in
patients who have congenital diaphragmatic hernia using preoperative
stabilization, extracorporeal membrane oxygenation, and delayed
surgery. J Pediatr Surg 1997, 32:1185-1189.
188. Bagolan P, Casaccia G, Crescenzi F, Nahom A, Trucchi A, Giorlandino C:
Impact of a current treatment protocol on outcome of high-risk
congenital diaphragmatic hernia. J Pediatr Surg 2004, 39:313-318.
189. Waag KL, Loff S, Zahn K, Ali M, Hien S, Kratz M, Neff W, Schaffelder R,
Schaible T: Congenital diaphragmatic hernia: a modern day approach.
Semin Pediatr Surg 2008, 17:244-254.
190. Karl SR, Ballantine TV, Snider MT: High-frequency ventilation at rates of
375 to 1800 cycles per minute in four neonates with congenital
diaphragmatic hernia. J Pediatr Surg 1983, 18:822-828.
191. Tamura M, Tsuchida Y, Kawano T, Honna T, Ishibashi R, Iwanaka T, Morita Y,
Hashimoto H, Tada H, Miyasaka K: Piston-pump-type high frequency
oscillatory ventilation for neonates with congenital diaphragmatic
hernia: a new protocol. J Pediatr Surg 1988, 23:478-482.
192. Fujino Y, Takezawa J, Nishimura M, Imanaka H, Taenaka N, Yoshiya I: High-
frequency oscillation for persistent fetal circulation after repair of
congenital diaphragmatic hernia. Crit Care Med 1989, 17:376-377.
193. Schnitzer JJ, Thompson JE, Hedrick HL: A new ventilator improves CO2
removal in newborn lambs with congenital diaphragmatic hernia. Crit
Care Med 1999, 27:109-112.
194. Reiss I, Schaible T, van den Hout L, Capolupo I, Allegaert K, van Heijst A,
Gorett Silva M, Greenough A, Tibboel D: Standardized postnatal
management of infants with congenital diaphragmatic hernia in Europe:
the CDH EURO Consortium consensus. Neonatology 2010, 98:354-364.
195. Collins DL, Pomerance JJ, Travis KW, Turner SW, Pappelbaum SJ: A new
approach to congenital posterolateral diaphragmatic hernia. J Pediatr
Surg 1977, 12:149-156.
196. Sumner E, Frank JD: Tolazoline in the treatment of congenital
diaphragmatic hernias. Arch Dis Child 1981, 56:350-353.
197. Bos AP, Tibboel D, Koot VC, Hazebroek FW, Molenaar JC: Persistent
pulmonary hypertension in high-risk congenital diaphragmatic hernia
patients: incidence and vasodilator therapy. J Pediatr Surg 1993,
28:1463-1465.
198. Weinberger B, Weiss K, Heck DE, Laskin DL, Laskin JD: Pharmacologic
therapy of persistent pulmonary hypertension of the newborn.
Pharmacol Ther 2001, 89:67-79.
199. Buss M, Williams G, Dilley A, Jones O: Prevention of heart failure in the
management of congenital diaphragmatic hernia by maintaining ductal
patency. A case report. J Pediatr Surg 2006, 41:e9-11.
Tovar Orphanet Journal of Rare Diseases 2012, 7:1
http://www.ojrd.com/content/7/1/1
Page 12 of 15
200. Finer NN, Etches PC, Kamstra B, Tierney AJ, Peliowski A, Ryan CA: Inhaled
nitric oxide in infants referred for extracorporeal membrane
oxygenation: dose response. J Pediatr 1994, 124:302-308.
201. Karamanoukian HL, Glick PL, Zayek M, Steinhorn RH, Zwass MS, Fineman JR,
Morin FC: Inhaled nitric oxide in congenital hypoplasia of the lungs due
to diaphragmatic hernia or oligohydramnios. Pediatrics 1994, 94:715-718.
202. Shah N, Jacob T, Exler R, Morrow S, Ford H, Albanese C, Wiener E, Rowe M,
Billiar T, Simmons R, et al: Inhaled nitric oxide in congenital
diaphragmatic hernia. J Pediatr Surg 1994, 29:1010-1014.
203. Kinsella JP, Parker TA, Ivy DD, Abman SH: Noninvasive delivery of inhaled
nitric oxide therapy for late pulmonary hypertension in newborn infants
with congenital diaphragmatic hernia. J Pediatr 2003, 142:397-401.
204. Lally KP: Congenital diaphragmatic hernia. Curr Opin Pediatr 2002,
14:486-490.
205. Hunter L, Richens T, Davis C, Walker G, Simpson JH: Sildenafil use in
congenital diaphragmatic hernia. Arch Dis Child Fetal Neonatal Ed 2009,
94:F467.
206. Masumoto K, Teshiba R, Esumi G, Nagata K, Takahata Y, Hikino S, Hara T,
Hojo S, Tsukimori K, Wake N, et al: Improvement in the outcome of
patients with antenatally diagnosed congenital diaphragmatic hernia
using gentle ventilation and circulatory stabilization. Pediatr Surg Int
2009, 25:487-492.
207. Bartlett RH, Gazzaniga AB, Toomasian J, Coran AG, Roloff D, Rucker R:
Extracorporeal membrane oxygenation (ECMO) in neonatal respiratory
failure. 100 cases. Ann Surg 1986, 204:236-245.
208. Dimmitt RA, Moss RL, Rhine WD, Benitz WE, Henry MC, Vanmeurs KP:
Venoarterial versus venovenous extracorporeal membrane oxygenation
in congenital diaphragmatic hernia: the Extracorporeal Life Support
Organization Registry, 1990-1999. J Pediatr Surg 2001, 36:1199-1204.
209. Guner YS, Khemani RG, Qureshi FG, Wee CP, Austin MT, Dorey F, Rycus PT,
Ford HR, Friedlich P, Stein JE: Outcome analysis of neonates with
congenital diaphragmatic hernia treated with venovenous vs
venoarterial extracorporeal membrane oxygenation. J Pediatr Surg 2009,
44:1691-1701.
210. Keckler SJ, Laituri CA, Ostlie DJ, St Peter SD: A review of venovenous and
venoarterial extracorporeal membrane oxygenation in neonates and
children. Eur J Pediatr Surg 2009, 20:1-4.
211. Azarow K, Messineo A, Pearl R, Filler R, Barker G, Bohn D: Congenital
diaphragmatic hernia–a tale of two cities: the Toronto experience. J
Pediatr Surg 1997, 32:395-400.
212. Morini F, Goldman A, Pierro A: Extracorporeal membrane oxygenation in
infants with congenital diaphragmatic hernia: a systematic review of the
evidence. Eur J Pediatr Surg 2006, 16:385-391.
213. Stolar CJ, Snedecor SM, Bartlett RH: Extracorporeal membrane
oxygenation and neonatal respiratory failure: experience from the
extracorporeal life support organization. J Pediatr Surg 1991, 26:563-571.
214. Payne NR, Kriesmer P, Mammel M, Meyer CL: Comparison of six ECMO
selection criteria and analysis of factors influencing their accuracy.
Pediatr Pulmonol 1991, 11:223-232.
215. Karimova A, Brown K, Ridout D, Beierlein W, Cassidy J, Smith J, Pandya H,
Firmin R, Liddell M, Davis C, Goldman A: Neonatal extracorporeal
membrane oxygenation: practice patterns and predictors of outcome in
the UK. Arch Dis Child Fetal Neonatal Ed 2009, 94:F129-132.
216. Mugford M, Elbourne D, Field D: Extracorporeal membrane oxygenation
for severe respiratory failure in newborn infants. Cochrane Database Syst
Rev 2008, CD001340.
217. UK collaborative randomised trial of neonatal extracorporeal membrane
oxygenation. UK Collaborative ECMO Trail Group. Lancet 1996, 348:75-82.
218. Moyer V, Moya F, Tibboel R, Losty P, Nagaya M, Lally KP: Late versus early
surgical correction for congenital diaphragmatic hernia in newborn
infants. Cochrane Database Syst Rev 2002, CD001695.
219. Liem NT, Dien TM, Ung NQ: Thoracoscopic repair in the neonatal
intensive care unit for congenital diaphragmatic hernia during high-
frequency oscillatory ventilation. J Laparoendosc Adv Surg Tech A 2009,
20:111-114.
220. Gavilanes AW, Heineman E, Herpers MJ, Blanco CE: Use of neonatal
intensive care unit as a safe place for neonatal surgery. Arch Dis Child
Fetal Neonatal Ed 1997, 76:F51-53.
221. Lago P, Meneghini L, Chiandetti L, Tormena F, Metrangolo S, Gamba P:
Congenital diaphragmatic hernia: intensive care unit or operating room?
Am J Perinatol 2005, 22:189-197.
222. Tyson KR, Schwartz MZ, Marr CC: “Balanced” thoracic drainage is the
method of choice to control intrathoracic pressure following repair of
diaphragmatic hernia. J Pediatr Surg 1985, 20:415-417.
223. Migliazza L, Bellan C, Alberti D, Auriemma A, Burgio G, Locatelli G,
Colombo A: Retrospective study of 111 cases of congenital
diaphragmatic hernia treated with early high-frequency oscillatory
ventilation and presurgical stabilization. J Pediatr Surg 2007, 42:1526-1532.
224. Grethel EJ, Cortes RA, Wagner AJ, Clifton MS, Lee H, Farmer DL,
Harrison MR, Keller RL, Nobuhara KK: Prosthetic patches for congenital
diaphragmatic hernia repair: Surgisis vs Gore-Tex. J Pediatr Surg 2006,
41:29-33.
225. Fei L, Saviano C, Moccia F, del Genio G, Trapani V, Nunziale A, Lombardi G,
Cecchi M: ePTFE soft tissue patch reconstruction of hemidiaphragmatic
agenesis with late clinical presentation. Hernia 2008, 12:103-106.
226. Loff S, Wirth H, Jester I, Hosie S, Wollmann C, Schaible T, Ataman O,
Waag KL: Implantation of a cone-shaped double-fixed patch increases
abdominal space and prevents recurrence of large defects in congenital
diaphragmatic hernia. J Pediatr Surg 2005, 40:1701-1705.
227. Atkinson JB, Poon MW: ECMO and the management of congenital
diaphragmatic hernia with large diaphragmatic defects requiring a
prosthetic patch. J Pediatr Surg 1992, 27:754-756.
228. Van Meurs KP, Robbins ST, Reed VL, Karr SS, Wagner AE, Glass P,
Anderson KD, Short BL: Congenital diaphragmatic hernia: long-term
outcome in neonates treated with extracorporeal membrane
oxygenation. J Pediatr 1993, 122:893-899.
229. Moss RL, Chen CM, Harrison MR: Prosthetic patch durability in congenital
diaphragmatic hernia: a long-term follow-up study. J Pediatr Surg 2001,
36:152-154.
230. Laituri CA, Garey CL, Valusek PA, Fike FB, Kaye AJ, Ostlie DJ, Snyder CL, St
Peter SD: Outcome of congenital diaphragmatic hernia repair depending
on patch type. Eur J Pediatr Surg 2010, 20:363-365.
231. Nasr A, Struijs MC, Ein SH, Langer JC, Chiu PP: Outcomes after muscle flap
vs prosthetic patch repair for large congenital diaphragmatic hernias. J
Pediatr Surg 2010, 45:151-154.
232. Scaife ER, Johnson DG, Meyers RL, Johnson SM, Matlak ME: The split
abdominal wall muscle flap–a simple, mesh-free approach to repair
large diaphragmatic hernia. J Pediatr Surg 2003, 38:1748-1751.
233. Sydorak RM, Hoffman W, Lee H, Yingling CD, Longaker M, Chang J, Smith B,
Harrison MR, Albanese CT: Reversed latissimus dorsi muscle flap for repair
of recurrent congenital diaphragmatic hernia. J Pediatr Surg 2003,
38:296-300.
234. Joshi SB, Sen S, Chacko J, Thomas G, Karl S: Abdominal muscle flap repair
for large defects of the diaphragm. Pediatr Surg Int 2005, 21:677-680.
235. Hosgor M, Karaca I, Karkiner A, Ucan B, Temir G, Erdag G, Fescekoglu O:
Associated malformations in delayed presentation of congenital
diaphragmatic hernia. J Pediatr Surg 2004, 39:1073-1076.
236. Imamoglu M, Cay A, Kosucu P, Ozdemir O, Orhan F, Sapan L, Sarihan H:
Congenital paraesophageal hiatal hernia: pitfalls in the diagnosis and
treatment. J Pediatr Surg 2005, 40:1128-1133.
237. Schnitzer JJ, Kikiros CS, Short BL, O’Brien A, Anderson KD, Newman KD:
Experience with abdominal wall closure for patients with congenital
diaphragmatic hernia repaired on ECMO. J Pediatr Surg 1995, 30:19-22.
238. Hasegawa T, Yoshioka Y, Sasaki T, Iwasaki Y, Tazuke Y, Sumimura J, Ban H,
Dezawa T: Abdominal wall plasty for a premature infant with congenital
diaphragmatic hernia. Pediatr Surg Int 1998, 13:48-51.
239. Kyzer S, Sirota L, Chaimoff C: Abdominal wall closure with a silastic patch
after repair of congenital diaphragmatic hernia. Arch Surg 2004,
139:296-298.
240. Nguyen TL, Le AD: Thoracoscopic repair for congenital diaphragmatic
hernia: lessons from 45 cases. J Pediatr Surg 2006, 41:1713-1715.
241. Becmeur F, Reinberg O, Dimitriu C, Moog R, Philippe P: Thoracoscopic
repair of congenital diaphragmatic hernia in children. Semin Pediatr Surg
2007, 16:238-244.
242. Shalaby R, Gabr K, Al-Saied G, Ibrahem M, Shams AM, Dorgham A, Ismail M:
Thoracoscopic repair of diaphragmatic hernia in neonates and children:
a new simplified technique. Pediatr Surg Int 2008, 24:543-547.
243. Cho SD, Krishnaswami S, McKee JC, Zallen G, Silen ML, Bliss DW: Analysis of
29 consecutive thoracoscopic repairs of congenital diaphragmatic hernia
in neonates compared to historical controls. J Pediatr Surg 2009, 44:80-86.
Tovar Orphanet Journal of Rare Diseases 2012, 7:1
http://www.ojrd.com/content/7/1/1
Page 13 of 15
244. Gourlay DM, Cassidy LD, Sato TT, Lal DR, Arca MJ: Beyond feasibility: a
comparison of newborns undergoing thoracoscopic and open repair of
congenital diaphragmatic hernias. J Pediatr Surg 2009, 44:1702-1707.
245. Kim AC, Bryner BS, Akay B, Geiger JD, Hirschl RB, Mychaliska GB:
Thoracoscopic repair of congenital diaphragmatic hernia in neonates:
lessons learned. J Laparoendosc Adv Surg Tech A 2009, 19:575-580.
246. Keijzer R, van de Ven C, Vlot J, Sloots C, Madern G, Tibboel D, Bax K:
Thoracoscopic repair in congenital diaphragmatic hernia: patching is
safe and reduces the recurrence rate. J Pediatr Surg 2010, 45:953-957.
247. Meehan JJ, Sandler A: Robotic repair of a Bochdalek congenital
diaphragmatic hernia in a small neonate: robotic advantages and
limitations. J Pediatr Surg 2007, 42:1757-1760.
248. McHoney M, Giacomello L, Nah SA, De Coppi P, Kiely EM, Curry JI,
Drake DP, Eaton S, Pierro A: Thoracoscopic repair of congenital
diaphragmatic hernia: intraoperative ventilation and recurrence. J Pediatr
Surg 2010, 45:355-359.
249. Lansdale N, Alam S, Losty PD, Jesudason EC: Neonatal endosurgical
congenital diaphragmatic hernia repair: a systematic review and meta-
analysis. Ann Surg 252:20-26.
250. van den Hout L, Reiss I, Felix JF, Hop WC, Lally PA, Lally KP, Tibboel D: Risk
factors for chronic lung disease and mortality in newborns with
congenital diaphragmatic hernia. Neonatology 2010, 98:370-380.
251. Downard CD, Jaksic T, Garza JJ, Dzakovic A, Nemes L, Jennings RW,
Wilson JM: Analysis of an improved survival rate for congenital
diaphragmatic hernia. J Pediatr Surg 2003, 38:729-732.
252. Doyle NM, Lally KP: The CDH Study Group and advances in the clinical
care of the patient with congenital diaphragmatic hernia. Semin Perinatol
2004, 28:174-184.
253. Hedrick HL, Crombleholme TM, Flake AW, Nance ML, von Allmen D,
Howell LJ, Johnson MP, Wilson RD, Adzick NS: Right congenital
diaphragmatic hernia: Prenatal assessment and outcome. J Pediatr Surg
2004, 39:319-323.
254. Fisher JC, Jefferson RA, Arkovitz MS, Stolar CJ: Redefining outcomes in
right congenital diaphragmatic hernia. J Pediatr Surg 2008, 43:373-379.
255. Bryner BS, Kim AC, Khouri JS, Drongowski RA, Bruch SW, Hirschl RB,
Mychaliska GB: Right-sided congenital diaphragmatic hernia: high
utilization of extracorporeal membrane oxygenation and high survival. J
Pediatr Surg 2009, 44:883-887.
256. Kamiyama M, Usui N, Tani G, Soh H, Kamata S, Nose K, Kubota A,
Fukuzawa M: Postoperative chylothorax in congenital diaphragmatic
hernia. Eur J Pediatr Surg 2010, 20:391-394.
257. Zavala A, Campos JM, Riutort C, Skorin I, Godoy L, Faunes M, Kattan J:
Chylothorax in congenital diaphragmatic hernia. Pediatr Surg Int 2010,
26:919-922.
258. Kavvadia V, Greenough A, Davenport M, Karani J, Nicolaides KH:
Chylothorax after repair of congenital diaphragmatic hernia–risk factors
and morbidity. J Pediatr Surg 1998, 33:500-502.
259. Goyal A, Smith NP, Jesudason EC, Kerr S, Losty PD: Octreotide for
treatment of chylothorax after repair of congenital diaphragmatic
hernia. J Pediatr Surg 2003, 38:E19-20.
260. Casaccia G, Crescenzi F, Palamides S, Catalano OA, Bagolan P: Pleural
effusion requiring drainage in congenital diaphragmatic hernia:
incidence, aetiology and treatment. Pediatr Surg Int 2006, 22:585-588.
261. Ijsselstijn H, Tibboel D, Hop WJ, Molenaar JC, de Jongste JC: Long-term
pulmonary sequelae in children with congenital diaphragmatic hernia.
Am J Respir Crit Care Med 1997, 155:174-180.
262. Nakayama DK, Motoyama EK, Mutich RL, Koumbourlis AC: Pulmonary
function in newborns after repair of congenital diaphragmatic hernia.
Pediatr Pulmonol 1991, 11:49-55.
263. Vanamo K, Rintala R, Sovijarvi A, Jaaskelainen J, Turpeinen M, Lindahl H,
Louhimo I: Long-term pulmonary sequelae in survivors of congenital
diaphragmatic defects. J Pediatr Surg 1996, 31:1096-1099.
264. Peetsold MG, Heij HA, Kneepkens CM, Nagelkerke AF, Huisman J, Gemke RJ:
The long-term follow-up of patients with a congenital diaphragmatic
hernia: a broad spectrum of morbidity. Pediatr Surg Int 2009, 25:1-17.
265. Muratore CS, Kharasch V, Lund DP, Sheils C, Friedman S, Brown C, Utter S,
Jaksic T, Wilson JM: Pulmonary morbidity in 100 survivors of congenital
diaphragmatic hernia monitored in a multidisciplinary clinic. J Pediatr
Surg 2001, 36:133-140.
266. Lund DP, Mitchell J, Kharasch V, Quigley S, Kuehn M, Wilson JM: Congenital
diaphragmatic hernia: the hidden morbidity. J Pediatr Surg 1994,
29:258-262.
267. Vanamo K, Peltonen J, Rintala R, Lindahl H, Jaaskelainen J, Louhimo I: Chest
wall and spinal deformities in adults with congenital diaphragmatic
defects. J Pediatr Surg 1996, 31:851-854.
268. Trachsel D, Selvadurai H, Bohn D, Langer JC, Coates AL: Long-term
pulmonary morbidity in survivors of congenital diaphragmatic hernia.
Pediatr Pulmonol 2005, 39:433-439.
269. Qi B, Soto C, Diez-Pardo JA, Tovar JA: An experimental study on the
pathogenesis of gastroesophageal reflux after repair of diaphragmatic
hernia. J Pediatr Surg 1997, 32:1310-1313.
270. Martinez L, Gonzalez-Reyes S, Burgos E, Tovar JA: The vagus and recurrent
laryngeal nerves in experimental congenital diaphragmatic hernia.
Pediatr Surg Int 2004, 20:253-257.
271. Stolar CJ, Berdon WE, Dillon PW, Reyes C, Abramson SJ, Amodio JB:
Esophageal dilatation and reflux in neonates supported by ECMO after
diaphragmatic hernia repair. AJR Am J Roentgenol 1988, 151:135-137.
272. Stolar CJ, Levy JP, Dillon PW, Reyes C, Belamarich P, Berdon WE: Anatomic
and functional abnormalities of the esophagus in infants surviving
congenital diaphragmatic hernia. Am J Surg 1990, 159:204-207.
273. Lally KP, Paranka MS, Roden J, Georgeson KE, Wilson JM, Lillehei CW,
Breaux CW Jr, Poon M, Clark RH, Atkinson JB: Congenital diaphragmatic
hernia. Stabilization and repair on ECMO. Ann Surg 1992, 216:569-573.
274. Vanamo K, Rintala RJ, Lindahl H, Louhimo I: Long-term gastrointestinal
morbidity in patients with congenital diaphragmatic defects. J Pediatr
Surg 1996, 31:551-554.
275. Fasching G, Huber A, Uray E, Sorantin E, Lindbichler F, Mayr J:
Gastroesophageal reflux and diaphragmatic motility after repair of
congenital diaphragmatic hernia. Eur J Pediatr Surg 2000, 10:360-364.
276. Tovar JA, Luis AL, Encinas JL, Burgos L, Pederiva F, Martinez L, Olivares P:
Pediatric surgeons and gastroesophageal reflux. J Pediatr Surg 2007,
42:277-283.
277. Dariel A, Roze JC, Piloquet H, Podevin G: Impact of prophylactic
fundoplication on survival without growth disorder in left congenital
diaphragmatic hernia requiring a patch repair. J Pediatr 2010,
157:688-690, 690 e681.
278. D’Agostino JA, Bernbaum JC, Gerdes M, Schwartz IP, Coburn CE, Hirschl RB,
Baumgart S, Polin RA: Outcome for infants with congenital diaphragmatic
hernia requiring extracorporeal membrane oxygenation: the first year. J
Pediatr Surg 1995, 30:10-15.
279. Ahmad A, Gangitano E, Odell RM, Doran R, Durand M: Survival, intracranial
lesions, and neurodevelopmental outcome in infants with congenital
diaphragmatic hernia treated with extracorporeal membrane
oxygenation. J Perinatol 1999, 19:436-440.
280. Rasheed A, Tindall S, Cueny DL, Klein MD, Delaney-Black V:
Neurodevelopmental outcome after congenital diaphragmatic hernia:
Extracorporeal membrane oxygenation before and after surgery. J
Pediatr Surg 2001, 36:539-544.
281. Bagolan P, Morini F: Long-term follow up of infants with congenital
diaphragmatic hernia. Semin Pediatr Surg 2007, 16:134-144.
282. Friedman S, Chen C, Chapman JS, Jeruss S, Terrin N, Tighiouart H,
Parsons SK, Wilson JM: Neurodevelopmental outcomes of congenital
diaphragmatic hernia survivors followed in a multidisciplinary clinic at
ages 1 and 3. J Pediatr Surg 2008, 43:1035-1043.
283. Lally KP, Engle W: Postdischarge follow-up of infants with congenital
diaphragmatic hernia. Pediatrics 2008, 121:627-632.
284. The collaborative UK ECMO (Extracorporeal Membrane Oxygenation)
trial: follow-up to 1 year of age. Pediatrics 1998, 101:E1.
285. Lasky RE, Wiorek L, Becker TR: Hearing loss in survivors of neonatal
extracorporeal membrane oxygenation (ECMO) therapy and high-
frequency oscillatory (HFO) therapy. J Am Acad Audiol 1998, 9:47-58.
286. Kuga T, Taniguchi S, Inoue T, Zempo N, Esato K: Hearing loss in infants
with congenital diaphragmatic hernia treated without extracorporeal
membrane oxygenation: report of two cases. J Pediatr Surg 2000,
35:621-623.
287. Robertson CM, Tyebkhan JM, Hagler ME, Cheung PY, Peliowski A, Etches PC:
Late-onset, progressive sensorineural hearing loss after severe neonatal
respiratory failure. Otol Neurotol 2002, 23:353-356.
Tovar Orphanet Journal of Rare Diseases 2012, 7:1
http://www.ojrd.com/content/7/1/1
Page 14 of 15
288. Fligor BJ, Neault MW, Mullen CH, Feldman HA, Jones DT: Factors
associated with sensorineural hearing loss among survivors of
extracorporeal membrane oxygenation therapy. Pediatrics 2005,
115:1519-1528.
289. Masumoto K, Nagata K, Uesugi T, Yamada T, Taguchi T: Risk factors for
sensorineural hearing loss in survivors with severe congenital
diaphragmatic hernia. Eur J Pediatr 2007, 166:607-612.
290. Morini F, Capolupo I, Masi R, Ronchetti MP, Locatelli M, Corchia C,
Bagolan P: Hearing impairment in congenital diaphragmatic hernia: the
inaudible and noiseless foot of time. J Pediatr Surg 2008, 43:380-384.
291. Javidnia H, Vaccani JP: Progressive sensorineural hearing loss in children
with congenital diaphragmatic hernias. J Otolaryngol Head Neck Surg
2009, 38:29-31.
292. Crane JP: Familial congenital diaphragmatic hernia: prenatal diagnostic
approach and analysis of twelve families. Clin Genet 1979, 16:244-252.
293. Wolff G: Familial congenital diaphragmatic defect: review and
conclusions. Hum Genet 1980, 54:1-5.
294. Norio R, Kaariainen H, Rapola J, Herva R, Kekomaki M: Familial congenital
diaphragmatic defects: aspects of etiology, prenatal diagnosis, and
treatment. Am J Med Genet 1984, 17:471-483.
295. Mishalany H, Gordo J: Congenital diaphragmatic hernia in monozygotic
twins. J Pediatr Surg 1986, 21:372-374.
296. Frey P, Glanzmann R, Nars P, Herzog B: Familial congenital diaphragmatic
defect: transmission from father to daughter. J Pediatr Surg 1991,
26:1396-1398.
297. Hitch DC, Carson JA, Smith EI, Sarale DC, Rennert OM: Familial congenital
diaphragmatic hernia is an autosomal recessive variant. J Pediatr Surg
1989, 24:860-864.
298. Gibbs DL, Rice HE, Farrell JA, Adzick NS, Harrison MR: Familial
diaphragmatic agenesis: an autosomal-recessive syndrome with a poor
prognosis. J Pediatr Surg 1997, 32:366-368.
299. Pober BR, Lin A, Russell M, Ackerman KG, Chakravorty S, Strauss B,
Westgate MN, Wilson J, Donahoe PK, Holmes LB: Infants with Bochdalek
diaphragmatic hernia: sibling precurrence and monozygotic twin
discordance in a hospital-based malformation surveillance program. Am
J Med Genet A 2005, 138A:81-88.
300. Pober BR: Overview of epidemiology, genetics, birth defects, and
chromosome abnormalities associated with CDH. Am J Med Genet C
Semin Med Genet 2007, 145C:158-171.
301. Bielinska M, Jay PY, Erlich JM, Mannisto S, Urban Z, Heikinheimo M,
Wilson DB: Molecular genetics of congenital diaphragmatic defects. Ann
Med 2007, 39:261-274.
302. Pober BR: Genetic aspects of human congenital diaphragmatic hernia.
Clin Genet 2008, 74:1-15.
doi:10.1186/1750-1172-7-1
Cite this article as: Tovar: Congenital Diaphragmatic Hernia. Orphanet
Journal of Rare Diseases 2012 7:1.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Tovar Orphanet Journal of Rare Diseases 2012, 7:1
http://www.ojrd.com/content/7/1/1
Page 15 of 15
